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1. INTRODUCTION 
Stem cells are characterised by two unique features that distinguish them from other types of 
cells. First, they have the ability of substantial self-renewal. The second is that they have the 
potential to differentiate into various cell types. During early mammalian development 
pluripotent stem cells give rise to all three germ layers. The proliferation and differentiation of 
these pluripotent stem cells are regulated by environmental factors and intrinsic signals.  
Human embryonic stem (hES) cells are pluripotent stem cells. By studying their biology 
important insight into early processes of human development can be gained which might be 
of major importance for future therapeutic applications. A prerequisite for such applications is 
to determine the conditions for the differentiation of hES cells into specific somatic cell types 
or even cellular subtypes. 
Of particular interest is the generation of cells of the central nervous system (CNS) as the 
CNS is characterised by unsurpassed complexity and unlike many other tissues of the 
human body, has a limited capacity for self-repair in response to injury.  
In the last few years increasing knowledge about hES cells, including the production of 
neural stem cells (NSCs) from hES cells has build the foundation for using hES cells for 
various applications. First of all, they provide the opportunity to study processes underlying 
the development of the human CNS in vitro. Secondly, they are candidates for future 
therapeutic applications in neurodegenerative diseases. For the latter, it is necessary to 
determine the factors that regulate NSC self-renewal for in vitro expansion, to understand 
how to differentiate NSCs into specific neural subtypes and how to produce sufficient 
numbers of ideally pure populations of such subtypes. Furthermore, it is necessary to identify 
the signals controlling progenitor cell migration. This may allow directing grafted cells to 
particular targets within the CNS.  
 
1.1.  Stem cells and their neurogenic potential 
Stem cells are undifferentiated cells that are able to self-renew and give rise to at least one, 
but often many specified cell types (Weissman, 2000a). They have varying repertoires. A 
pluripotent stem cell can give rise to every cell of the organism except the trophoblast of the 
placenta (Gage, 2000). A multipotent stem cell can only give rise to cells of specific tissues 
(van der Kooy & Weiss, 2000). To maintain a stable stem cell population and at the same 
time produce restricted daughter cells, the division of stem cells is often asymmetric, 
meaning one daughter cell differentiates into a more mature progeny, while the other 
daughter cell remains a stem cell (Knoblich, 2001). Although stem cells should be able to 
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divide without limits, they do not have to divide rapidly. In fact later in life, many stem cells 
divide at a relatively low rate (Donovan & Gearhart, 2001).  
Embryonic stem (ES) cells, which can be derived from the inner cell mass of blastocysts 
(Smith, 2001) are pluripotent, which means that they can differentiate into cells derived from 
any of the three germ layers. Somatic stem cells, which can be found throughout the body 
during and after embryonic development are multioptent, meaning they can only differentiate 
into tissue specific cell types. A wide variety of adult mammalian tissues including CNS, bone 
marrow, skeletal muscle, intestine, pancreas, liver and epidermis harbour somatic stem cells 
(Hall & Watt, 1989; Potten & Loeffler, 1990; Weissman, 2000b). They are needed to maintain 
tissue homeostasis and repair lesions after an injury. NSCs are the somatic stem cells of the 
nervous system. They appear in the embryonic mammalian CNS (Cattaneo & McKay, 1990; 
Reynolds & Weiss, 1992; Kilpatrick & Bartlett, 1993; Temple, 2001) and the peripheral 
nervous system (PNS) (Stemple & Anderson, 1992). Adult NSCs have been found mainly in 
two adult neurogenic regions: the hippocampus and the subventricular zone (SVZ), but also 
in some non-neurogenic regions including the spinal cord (McKay, 1997; Rao, 1999; Gage, 
2000).  
 
1.1.1. Generation of pluripotent stem cells  
There are different ways to generate pluripotent stem cells. For instance, pluripotent ES cells 
can be obtained from the inner cell mass of blastocysts (Figure 1.1) (Smith, 2001).  
 
 
Figure 1.1: Generation of embryonic 
stem cell cultures. The inner cell mass 
of a pre-implantation embryo is isolated 
and cultivated on fetal fibroblasts. Cell 
lines can be established by dissociation 
and propagation of the obtained colonies. 
Adopted from Winslow & Duckwall 
(Winslow & Duckwall, 2001). 
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For this purpose, the inner cell mass is isolated and plated onto fibroblasts to maintain the 
undifferentiated state of the isolated ES cell. The developing ES cell colonies can then be 
further cultivated. ES cells have until now been generated from various species, including 
humans (Thomson et al., 1998). More recently, ES-like cells have also been isolated from 
later stage blastocysts and also from the morula stage (Stojkovic et al., 2004; Strelchenko et 
al., 2004). For the generation of ES cells through therapeutic cloning, the nucleus of a 
somatic stem cell is transferred into an enucleated oocyte (Wilmut et al., 1997). By isolating 
the inner cell mass of the developing blastocyst, ES cells with the same nuclear genome as 
the donor cell can be obtained.  
Recent studies also showed the generation of induced pluripotent stem (iPS) cells, which is a 
type of pluripotent stem cell artificially derived from a non-pluripotent cell such as neonatal or 
adult human fibroblasts, by transcription factor-based reprogramming (Figure 1.2) 
(Takahashi & Yamanaka, 2006; Okita et al., 2007; Wernig et al., 2007).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2: Generation of iPS cells. Specialised cells from fetal tissue can be rejuvenated and 
reprogrammed into cells resembling ES cells by introducing master transcription regulators into the 
cells, followed by a selection process to isolate reprogrammed cells. These cells resemble ES cells in 
that they display key properties of self-renewal and the ability to mature into many different cell types. 
The latter were observed in embryoid bodies, in teratomas and in chimeras (Surani & McLaren, 2006). 
 
The reprogramming is typically achieved via virus-mediated gene transfer of master 
transcription regulators such as Oct-3/4, Sox2, Klf4, c-myc, Nanog and Lin28 (Nakagawa et 
al., 2008). After 3-4 weeks, small numbers of transfected cells start to become 
Fibroblasts 
Retroviral 
transfection 
(Oct3/4, Sox2, 
Klf4, c-myc) 
 
Isolation of 
reprogrammed ES-
like cell colonies 
Self-renewal 
Embryoid body Teratoma  Chimaera 
Differentiation  
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morphologically and biochemical similar to pluripotent stem cells. They can be isolated by 
virtue of their morphology, doubling time or a reporter gene expression. Ongoing studies are 
comparing iPS cells to ES cells, for identifying similarities and differences between these 
pluripotent stem cells. The expression of certain stem cell genes, DNA methylation patterns, 
doubling time, teratoma and chimera formation, and their differentiation potential are 
currently under investigation (Maherali et al., 2007; Wernig et al., 2007).  
Pluripotent stem cells generated by therapeutic cloning or by transcription factor-based 
reprogramming may offer major advantages for cell replacement strategies. On the one 
hand, patient-specific pluripotent stem cell lines could be generated to prevent rejection of 
transplanted cells. On the other hand, human pluripotent stem cell lines with the genotype of 
specific human diseases could be generated. These cells could then be differentiated in vitro 
into relevant populations, such as dopamine neurons from Parkinsonʼs patients. This would 
enable the study of disease pathogenesis in vitro and the development of new treatment 
strategies.  
However, there are still concerns with respect to potential therapeutic applications of such 
pluripotent stem cells. While the use of hES cells generated through therapeutic cloning 
bears various ethical problems, the generation of iPS cells have major biological drawbacks. 
The current need of viral transfection of potentially oncogenic factors include the risk of 
insertion mutagenesis. This can lead to the creation of cells, which might undergo 
uncontrolled proliferation and tumorigenesis. Even though iPS cells can be generated from 
mouse and human fibroblasts without the oncogenic c-myc retrovirus, the reprogramming 
efficiencies are thereby decreasing strongly (Marson et al., 2008; Nakagawa et al., 2008). 
Because of that, the method of cre-mediated excision of the integrated c-myc carrying viral 
genome from the iPS cells might be a useful tool for the eventual application of iPS cells in 
human therapies (Hanna et al., 2007). Efforts are also focusing on identifying alternatives to 
the viral delivery system such as using small molecules (Huangfu et al., 2008), protein 
transduction of reprogramming factors (Bosnali et al., 2008) or a plasmid-mediated system 
(Okita et al., 2008) to generate iPS cells.  
 
1.1.2. Strategies for the differentiation of pluripotent stem cells 
For tissue regeneration and other biomedical applications pluripotent stem cells need to be 
differentiated into tissue specific cell types. A large variety of different cell types have already 
been generated from mouse and human ES cells including neural cells (Okabe et al., 1996; 
Reubinoff et al., 2001; Zhang et al., 2001), cardiomyocytes (Xu et al., 2002; Laflamme et al., 
2007), insulin-producing cells (Soria et al., 2005; D'Amour et al., 2006; Schroeder et al., 
2006), and several others. Key prerequisites for the biomedical application of ES cell-derived 
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somatic cell types are purity and cell type specification, as residual pluripotent ES cells may 
cause the formation of teratomas after transplantation (Thomson et al., 1998; Amit et al., 
2000; Reubinoff et al., 2001). Generally, two different strategies exist for the generation of 
highly enriched somatic cell populations: directed differentiation and lineage selection (Figure 
1.3).  
 
 
 
 
 
 
 
 
 
     
 
Figure 1.3: Strategies for the generation of pluripotent stem cell derived enriched somatic cell 
types. Directed differentiation is based on the sequential treatment with specific growth factors in 
defined media, guiding all cells towards the desired phenotype. For lineage selection, all cells are 
differentiated spontaneously into several phenotypes. The desired phenotype can then be isolated by 
cell type-specific selectable markers. Adopted from Wernig et al. (modified) (Wernig et al., 2003). 
 
The directed differentiation in vitro is based on the application of specific media compositions 
and extrinsic factors in a defined manner and sequence (Schuldiner et al., 2000). The aim of 
this strategy is to induce the entire cell population to differentiate into the desired cell type. 
Early methods to direct the differentiation of ES cells to neural fates used retinoic acid 
treatment (Bain et al., 1995), sequential culture in serum and serum-free media (Okabe et al., 
1996) or co-culture with specific stromal cell lines such as PA6 (Kawasaki et al., 2000). 
Recently, several protocols were established to differentiate ES cells into NSCs (see also 
1.1.3) (Conti et al., 2005; Koch et al., 2006). Although generating cells with a neural 
phenotype from ES cells is well established, it should be noted that there are many neuronal 
and glial subtypes with different physiological functions. Therefore, obtaining a purified 
subtype for basic research or for tissue repair is considerably more challenging. To achieve 
this, directed differentiation into NSCs has been combined with lineage selection. Lineage 
selection is based on the selection of a desired phenotype from a pool of heterogeneously 
differentiated cell types. Cells can be either selected on the basis of the expression of a 
specific surface antigen by immunological methods like immunopanning, magnetic or 
fluorescence activated cell sorting (FACS) (Roy et al., 1999; Malatesta et al., 2000; Roy et 
Directed differentiation Lineage selection 
Factor B Factor A 
Factor C 
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al., 2000a; Carpenter et al., 2001; Schmandt et al., 2005), or by genetically modifying the ES 
cells or the ES cell derived NSCs with a selectable marker only expressed in the desired cell 
population. For selection, an antibiotic resistance gene or a fluorescence reporter gene under 
the control of a cell type-specific promoter is commonly used. The mixed cell population is 
either treated with a specific antibiotic, allowing only those cells to survive which express the 
marker, or subjected to FACS, which again leads to the enrichment of those cells expressing 
specifically a fluorescent protein in the desired cell type (Klug et al., 1996; Roy et al., 1999; 
Rietze et al., 2001; Pasumarthi & Field, 2002; Wernig et al., 2002; Glaser et al., 2005).  
 
1.1.3. Long-term self-renewing neuroepithelial stem cells from hES cells 
In the laboratory where the presented work was performed Koch and co-workers established  
a population of stably proliferating neural stem cells from hES cells (lt-hESNSC) (Koch et al., 
2006; Koch et al., in revision). These cells can be expanded as adherent homogeneous 
monolayer across more than 100 passages, have a stable neurogenic differentiation pattern 
and are amenable to genetic modification (Koch et al., 2006; Ladewig et al., 2008), thereby 
overcoming many of the shortcomings of previously available cell populations. 
Immunhistochemical data and transcription factor expression data showed that under 
standard conditions these cells adopt a highly restricted regional identity comparable to an 
anterior and ventral hindbrain localization, an area with close spatial relationship to ventral 
mesencephalic progenitors. It was possible to demonstrate that even after extensive 
passaging these cells can be recruited into adjacent regional identities such as ventral 
midbrain dopaminergic neurons or spinal cord motoneurons. Furthermore, first direct 
evidence was provided for synaptic integration of lt-hESNSC-derived neurons into brain 
tissue after transplantation (Koch et al., in revision).  
The lt-hESNSC culture system provided an important basic for the studies presented in this 
work. 
 
1.1.4. Potential therapeutic use of stem cells in CNS disorders 
The CNS has a very limited regenerative capacity. Thus it is of major interest to investigate 
the ability of human NSCs engrafted into the brain to survive, migrate and integrate in a 
functional and meaningful manner. 
Studies have shown that stem cells derived from the embryonic or fetal human brain can be 
successfully grafted into the developing rodent CNS. Once transplanted, these cells survive, 
migrate and integrate into the host tissue, giving rise to cells from the three fundamental 
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neuronal lineages i.e. neurons, astrocytes and oligodendrocytes (Brustle et al., 1998; Flax et 
al., 1998; Uchida et al., 2000; Englund et al., 2002b; Peng et al., 2002; Honda et al., 2007).  
However, transplantation studies in the adult CNS are more challenging. As the tissue is fully 
established, developmental cues are limited and space is more constricted (Svendsen & 
Caldwell, 2000) leading to restricted migration and integration of the transplanted cells. 
Engraftment of fetal or ES cell derived neural progenitors in the adult CNS could show that 
transplanted cells survive but form a graft core meaning that the majority of the transplanted 
cells remain mainly situated at the grafted site (Guzman et al., 2008). Restricted migration of 
the transplanted cells could be observed 10 to 15 weeks following engraftment (Fricker et al., 
1999; Aleksandrova et al., 2002; Englund et al., 2002a; Tabar et al., 2005; Roy et al., 2006; 
Guzman et al., 2008). It was suggested that physical or molecular barriers caused by glial 
scarring at the transplantation site are the reason for the restricted outgrowth of transplanted 
cells (Reier et al., 1983; Rudge & Silver, 1990). Such effect might be solved by micro-
transplants, which minimize scarring at the grafted site (Nikkhah et al., 1995; Davies et al., 
1997). 
Nevertheless, cell replacement therapies for diseases of the adult brain have attracted 
attention since the first reports of successful transplantation of embryonic dopaminergic cells 
to patients with Parkinsonʼs disease (Lindvall & Hagell, 2001). Parkinsonʼs disease is 
characterized by a loss of dopamine-producing midbrain neurons with cell bodies in the 
substantia nigra. These neurons project to the striatum and are essential for motor function. 
Parkinsonʼs patients suffer from various symptoms including resting tremor, difficulty in 
walking, and loss of facial expression. The disease is typically progressive due to ongoing 
loss of neurons. The first transplantation studies with fetal tissue in animal models of 
Parkinsonʼs disease have shown that grafted dopaminergic cells are able to release 
dopamine at near normal levels and that the animals show significant behavioural recovery 
(Annett et al., 1994; Herman & Abrous, 1994; Lindvall et al., 1994). Positive effects have also 
been observed in clinical trails with human patients (Olanow et al., 1996; Lindvall, 1999). 
Major improvements, however, were only seen in patients aged 60 years or younger (Freed 
et al., 2001). Moreover, some patients receiving transplants developed dyskinesias, 
movement disorders associated with excessive dopamine levels in the brain. Further 
success of these transplantation approaches has been constrained by limited availability of 
fetal tissue, limited migration of grafted cells, and poor differentiation and survival of the 
grafted neurons (Richardson et al., 2004). In addition to these problems, fresh fetal tissue 
cannot be standardized and raises ethical questions that have been debated intensely 
(Bjorklund & Lindvall, 2000).  
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Many of these issues can be better addressed by working towards an in vitro culture system. 
The knowledge about hES cells, including techniques of producing stable well-characterised 
NSCs from hES cells has provided prospects to generate large numbers of donor cells for 
neural repair. Many studies already show that neural progenitors derived from ES cells can 
give rise to dopaminergic neurons. This is mainly achieved by the combined use of FGF8 
and Shh, which effectively induce dopaminergic neurons from ES cell-derived neural 
progenitors (Lee et al., 2000; Yan et al., 2005). Addition of ascorbic acid, brain-derived 
neurotrophic factor (BDNF), glial-derived neurotrophic factor (GDNF), dibutyryl cyclic-AMP, 
and transforming growth factor-beta 3 (TGF-β3) yields cultures containing 30% to 50% 
neurons expressing beta-III tubulin, of which 65% to 80% express tyrosine hydroxylase 
required for dopamine synthesis. These neurons release dopamine upon depolarization, and 
form at least rudimentary synapses in vitro with transmitter re-uptake abilities (Kim et al., 
2007; Joannides et al., 2007). Following transplantation these cells survive, maintain their 
dopaminergic phenotype and functionally engraft in the brain (Sanchez-Pernaute et al., 2005; 
Yang et al., 2008). Using cultured ES cell-derived neural precursors as a source for 
transplantation therapies may, on the one hand, obviate some of the technical limitations 
associated with the use of fresh fetal tissue (Ostenfeld & Svendsen, 2003), but may also on 
the other hand, bear the risk of teratoma formation. Currently, the only way to ensure that 
teratomas do not form is to differentiate the ES cells in advance, enrich for the desired cell 
type and screen for the presence of undifferentiated cells. In addition, hES cell-derived neural 
precursor transplants have been found to give rise to proliferating neural clusters rather than 
individually incorporating neurons (Roy et al., 2006) indicating that even committed 
progenitors can proliferate excessively after transplantation. This problem might be solved by 
using more restricted precursor cells or by the purification of desired postmitotic subtypes of 
neurons or glia. 
Compared to cell replacement therapy for Parkinsonʼs disease, in which one specific type of 
neurons has to be replaced by a direct local cell transplantation, cell therapy for stroke or 
spinal cord injury is a major challenge as transplanted NSCs need to replace a range of 
neuronal types, remyelinate axons and repair complex neural circuitries. In addition, it is 
required that transplanted cells reach the lesion site by following a gradient of inflammatory 
cues such as cytokines and chemokines (Ransohoff, 2002). As a preliminary step towards 
this goal, it was shown that human NSCs transplanted into the brains of rodents after stroke 
survived, migrated, and differentiated into various types of neurons (Aoki et al., 1993; Ben-
Hur et al., 2003; Imitola et al., 2004; Kelly et al., 2004). Other degenerative diseases of the 
adult CNS such as Alzheimerʼs disease and amyotrophic lateral sclerosis would also require 
the migration of transplanted cells towards specific sites within the CNS. Many 
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neurodegenerative diseases are associated with a non-permissive environment, which can 
inhibit regenerative processes. These circumstances create an even bigger challenge for cell 
replacement therapy.  
 
Thus, the major difficulties yet to be solved are how to direct and control the differentiation of 
specific phenotypes required for replacement and repair in each disease, how to purify 
lineage specific subtypes and how to improve cell migration and integration into the affected 
site of the CNS.  
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1.2. Cell migration in the vertebrate CNS 
 
Neurons of the vertebrate CNS migrate from their places of birth to their location of function. 
During the last few years, significant progress has been made in the understanding of the 
molecular mechanisms, which control neuronal migration, either during development or 
within the adult CNS. Hence, the developing and adult CNS provides insight into the complex 
mechanisms involved in neuronal migration, which is a vital component for learning how to 
enhance the migration and integration of grafted NSCs for future neuronal cell replacement 
strategies.  
1.2.1. Migration in early CNS development  
In vertebrates the early embryo is divided into three germ layers: ectoderm, mesoderm and 
endoderm. The CNS, including the brain, the spinal cord and the retina of the eye, arises 
from the ectoderm. During development the ectoderm thickens depending on inductive 
signals from the underlying mesoderm to form the neural plate. During neurulation the neural 
plate folds and forms the neural tube (Kandel, 2000) (Figure 1.4). At that stage the neural 
tube consists of a single layer of rapidly dividing NSCs. Extensive proliferation within the 
germinal neuroepithelium leads to the generation of two different cell populations forming the 
ventricular zone (VZ) i.e. radial glial cells through symmetric cell division and neuroblasts 
through asymmetric cell division. During further development asymmetric cell division 
replaces the initial symmetric cell division of the radial glial cells and neural precursor cells 
arise (Temple, 2001). Radial glial cells span through the neuroepithelium while keeping 
attached to the pial surface and the luminal side of the neural tube. They serve as guiding 
tracks for neuroblasts, which migrate along the radial glial cells to the pial side where they 
settle as post mitotic neurons (Rakic, 1972). The neuroepithelial stem cells also give rise to 
another population of adult NSCs generating the SVZ. The regional identity of the cells at 
different positions along the dorsal-ventral axis of the tube is specified by the antagonistic 
signalling of the primary bone morphogenetic protein (BMP) and sonic hedgehog (Shh). The 
anterior-posterior axis is specified by various morphogens including fibroblast growth factors 
(FGFs), Wnt proteins and retinoic acid (RA) (Liu & Niswander, 2005). The extent of cell 
proliferation is not uniform and therefore results in the formation of the three brain vesicles: 
the prosencephalon, the mesencephalon and the rhombencephalon. The prosencephalon 
later gives rise to various structures of the brain including the cerebral cortex, the 
hippocampus, the thalamus and the olfactory bulb. 
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1.2.2. Mechanisms of neuronal migration in the CNS  
Following the patterning of the neural tube, cell migration plays an essential role in the 
formation of the CNS. Once the cells are specified, they migrate away from the ventricular 
zone to their final destination. The most complex migration can be found in the forebrain 
where cellular movement creates an organized structure of cell layers consisting of different 
neuronal subtypes which later give rise to the cerebral cortex. Two different types of 
migration have been identified in the forebrain: radial migration and tangential migration 
(Marin & Rubenstein, 2003).  
 
Radial migration of neural precursor cells from the VZ towards the pial surface involves at 
least two different types of movement: soma translocation and glia-guided migration 
(Nadarajah, 2003) (Figure 1.5). Soma translocation is prevalent during early stages of 
cortical development and appears to be largely independent of radial glial cells (Morest, 
1970; Nadarajah & Parnavelas, 2002). In glia-guided migration, neurons migrate along a 
radial glial scaffold which extends from the inner to the outer surface of the neural tube 
(Rakic, 1972) and receive guidance as they migrate. In soma translocation, however, the 
route is determined before the somata leave the VZ (Hatten, 1990; Rakic et al., 1994). Neural 
precursor cells migrate radially from the VZ towards the pial surface, building up the cortical 
Figure 1.4: Formation of the neural tube. (a) The 
CNS arises from a specialised epithelium: the neural 
plate. (b) During neurulation the neurale plate folds, 
(c) the lateral edges of the neural plate fuse and (d) 
segregate from the non-neural epithelium to form the 
neural tube. Neural crest cells derived from the dorsal 
neural tube migrate out to form the PNS, 
melanocytes and cartilage in the head. Adopted from 
Liu & Niswander (Liu & Niswander, 2005).  
a 
b 
c 
d 
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cell layers in an inside to outside manner. As a result, each newly generated neuron migrates 
past the previously formed neuron (Rakic et al., 1974; Nadarajah & Parnavelas, 2002). 
Subsets of neurons also migrate parallel to the surface of the brain in a tangential orientation 
(Hatten, 1999; Nadarajah & Parnavelas, 2002; Marin & Rubenstein, 2003) (Figure 1.5). 
During development, neurons migrate tangentially from the subpallium towards the cerebral 
cortex and the hippocampus (Corbin et al., 2001). These neurons invade the cortex along the 
marginal zone or through the cerebral wall in a manner that is presumed to be independent 
of radial glial cells and give rise primarily to GABAergic interneurons (Stuhmer et al., 2002). 
Some neurons can switch dynamically between tangential and radial migration as frequently 
observed in cortical interneurons, cerebellar granule neurons (Komuro & Rakic, 1995; 
Polleux et al., 2002) and in spinal cord dorsal column neurons (Gray et al., 1990).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Aside from the neuronal migration within the developing CNS neuronal migration also takes 
place in the adult CNS as neurons are constantly generated throughout adulthood from 
NSCs. These NSCs occupy specific niches in the dentate gyrus of the hippocampus 
(Eriksson et al., 1998; Roy et al., 2000b) and in the lateral ventricle SVZ and subcortical 
white matter (Lois & Alvarez-Buylla, 1993; Palmer et al., 1997; Doetsch et al., 1999; Temple, 
2001; Doetsch, 2003). The NSC niche in the rodent CNS comprises several types of cells. 
Firstly, a layer of ependymal cells, which line the ventricle regions and shield the NSC niche 
from the ventricle. Secondly, NSCs, which are located adjacent to the ependymal cells and 
Figure 1.5: Radial and tangential migration of 
neurons in the developing cortex. Radially 
migrating neurons either use (a) soma 
translocation with a long leading process or (b) 
migrate in close proximity to a radial glial process 
(blue). Tangentially migrating neurons (purple) 
invade the cortex along the marginal zone or 
through the cerebral wall in a manner that is 
presumed to be independent of radial glial cells. 
Adopted from Ghashghaei et al.  (Ghashghaei et 
al., 2007). 
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extend with a single cilium structure through the boundary of ependymal cells to contact the 
ventricle region. NSCs divide and give rise to transit-amplifying cells, which in turn give rise 
to migratory neuroblasts (Figure 1.6). Both, in the SVZ and in the SGZ, blood vessels and the 
specialised basal lamina derived from endothelial cells represent essential components of 
the NSC niche. They are supposed to generate a variety of signals that control stem cell self-
renewal and lineage commitment.  
                                        
Figure 1.6: Schematic illustration of the SVZ NSC niche in the rodent brain. (a) The SVZ is 
located next to the lateral ventricle (LV) in the brain. (b) A detail of the lateral wall of the lateral 
ventricle. Lineage committed (post mitotic) migratory neuroblasts (red), NSCs (blue) and transit 
amplifying cells (green), the basal lamina (arrow), ciliated ependymal cells (grey) and brain 
microvessels (yellow) are in physical contact with each other to form the NSC niche. Cortex (Cx), 
corpus callosum (CC), striatum (St). Adopted from Martino & Pluchino (Martino & Pluchino, 2006). 
 
Neuroblasts born in the SGZ migrate a short distance into the overlying dentate gyrus (Gage, 
2000) whereas neuroblasts born in the SVZ migrate a long distance towards the olfactory 
bulb, where they differentiate into interneurons (Alvarez-Buylla et al., 2001). Apart from radial 
and tangential migration, neuroblasts migrating long distances use a third mode of migration 
called chain migration (Lois & Alvarez-Buylla, 1994). Migrating cells which form chain-like 
structures appear to be either attached to one another, or attached to axons of neighbouring 
neurons (Lois et al., 1996). These observations have lead to the conclusion that chain 
migration might be independent of glial cells. It is thought that these neurons are more likely 
to use corticofugal fibres, marginal zone neurons or the pial membrane as migratory guides. 
In the rostral migratory stream, however, tubes of astrocytic cells appear to be surrounded by 
chains of migrating neurons (Doetsch & Alvarez-Buylla, 1996), indicating that glial cells may 
play an active role in the regulation of chain migration (Mason et al., 2001).  
 
Neuronal migration, either in the developing or adult CNS involves four steps as follows. The 
first step is the initiation when the cell is activated from the stationary state to a mobile form. 
During this process the cell extends a leading neurite preceded by a growth cone that 
extends and contacts as it explores the microenvironment. During such manoeuvres the 
a b 
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nucleus and cell soma remain largely immobile. It is not until the leading neurite is 
consolidated and bipolar morphology acquired that soma translocation actually occurs 
(Lambert de Rouvroit & Goffinet, 2001). In a second step the nucleus moves towards a 
leading process called nucleokinesis which critically depends on the cytoskeleton (Morris et 
al., 1998). Nucleokinesis begins with the stabilization of the leading process. The centrosome 
moves into the neurite quickly followed by the translocation of the nucleus towards the 
centrosome (Schaar & McConnell, 2005; Tsai & Gleeson, 2005). Once motile, the cell must 
maintain the migratory state and respond to guidance cues to find its final position. The third 
step is the retraction of the tailing process, which currently is poorly understood. Finally, 
unlike other cells, neurons form defined structures when reaching their final destination which 
is the fourth step of neuronal migration (Lambert de Rouvroit & Goffinet, 2001).  
 
1.2.3. Factors regulating neuronal migration in the CNS 
All steps involved in neuronal migration depend on extracellular cues such as various 
extracellular matrix components, growth factors and neurotransmitters either generated from 
cells of the NSC niche or from the surrounding tissue (Figure 1.7). These extracellular cues 
act through intracellular signalling cascades which in turn regulate the cytoskeletal machinery 
leading to cell locomotion mechanisms (Sobeih & Corfas, 2002). Studying the role of the 
extracellular cues on neuronal migration in the embryonic and adult CNS can teach us 
important lessons about the complex mechanisms involved in neuronal migration following 
NSC transplantation.  
                            
Figure 1.7: Summary scheme of putative molecules governing neuroblast migration from the 
NSC niche in the SVZ towards the olfactory bulb. Influences of diffusible factors, cell-cell and cell-
ECM interactions on migration are illustrated. Neuroblasts (NB), astrocytes (A) and radial glia (RG). 
Adopted from Menezes et al. (Menezes et al., 2002). 
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It has recently been suggested that EGF and TGFα play significant roles in radial migration 
in the cortex. The EGFR and its ligands, heparin-binding EGF (HB-EGF) and TGFα, are 
expressed in the germinal layers of the telencephalon. Mice lacking the EGFR show 
accumulation of neuronal precursors in the telencephalic proliferative zone, suggesting a 
defect in their migration (Threadgill et al., 1995). In addition, a study using a replication 
defective retrovirus, provided evidence that the ability of neural cells to migrate depends on 
their level of EGFR expression, with cells overexpressing EGFR displaying increased radial 
migration in the cortex and olfactory bulb (Caric et al., 2001). Another growth factor that has 
been shown to be crucial for neuronal migration is FGF2. FGF2 deficient mice have an 
abnormal organization of the cerebral cortex, caused by a failure of neural progenitors to 
migrate to their target layer (Dono et al., 1998).   
Neurotrophins, including BDNF and neurotrophin-4 (NT-4), which are known to act as neural 
survival factors, have also been shown to affect neuronal migration by regulating the 
expression of reelin (Brunstrom et al., 1997; Sobeih & Corfas, 2002, Ringstedt, 1998) which 
is the best studied extracellular matrix (ECM) protein involved in neuronal migration 
(Frotscher, 1997; D'Arcangelo & Curran, 1998). Reelin is thought to function by allowing 
migrating neuronal cells to detach from the radial glia, as they reach the cortical surface and 
thereby making it possible for younger neurons to pass the older ones (Dulabon et al., 2000). 
That would explain the inverted layering in the cerebral cortex seen in reelin mutatants (see 
1.2.4) (Rice & Curran, 2001). Laminins and HSPGs are other components of the ECM that 
are known to influence neuronal migration (Liesi et al., 1995; Hu, 2001).  
Integrins and cell adhesion molecules (CAMs) are cell surface molecules that have been 
reported to be involved in the regulation of neuronal migration. Integrin α6β1 which is found 
to be expressed in neuroblasts, functions by linking the cell membrane with the ECM. 
Blocking of integrin α6β1 was shown to inhibit chain migration (Rice & Curran, 2001). Integrin 
ligands such as laminins have been found to be involved in the migration of cerebellar 
granule cells (Liesi et al., 1995). CAMs are important for cell-cell recognition by affecting the 
adhesiveness of neurons to other neurons and to the ECM. Studies showed that mice lacking 
N-CAM (neural-CAM) exhibit a decreased migration of neural precursors along the rostral 
migratory stream resulting in a reduction in size of the olfactory bulb (Chazal et al., 2000).  
Furthermore, cell junctions play a role in neuronal migration. Recent studies showed that gap 
junction subunits connexin 26 (Cx26) and connexin 43 (Cx43) are expressed at the contact 
points between radial fibers and migrating neurons, and acute down regulation of the Cx26 or 
Cx43 impairs migration of neurons to the cortical plate. The gap junctions provide dynamic 
adhesive contacts that interact with the internal cytoskeleton to enable leading process 
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stabilisation along radial glial fibers as well as the subsequent translocation of the nucleus. 
They are necessary for glia-guided neuronal migration (Elias et al., 2007).  
Soluble factors create chemical gradients that are critical for neural migration. These factors 
are generated from the surrounding tissue and include attractive and repulsive molecules 
such as netrins, semaphorins, ephrins, slit, and various neurotrophic factors (Figure 1.7) 
(Marin et al., 2003; Marin & Rubenstein, 2003). Slit is expressed in the septum and acts in 
combination with astrocyte-derived migration-inducing activity (MIA) as a repellent for SVZ 
cells to migrate towards the olfactory bulb (Mason et al., 2001). Ephrins are expressed 
throughout the rostral migratory stream and are associated with astrocytes functioning in 
axonal pathfinding (Conover et al., 2000). Netrin is expressed among others by cells of the 
olfactory bulb and acts as an attractant by influencing the orientation of the leading 
processes of neurons expressing the netrin receptor DCC (deleted in colorectal cancer) 
(Alcantara et al., 2000). Chemokines are another family of soluble factors with over 40 
proteins involved in migration in the CNS. They typically signal through specific 
transmembrane G-protein-coupled receptors and were originally identified as factors 
modulating the migration of leukocytes. Studies in the developing cerebellum showed the 
expression of the chemokine SDF-1 in cerebellar pia and its receptor CXCR4 in granule cell 
precursors. Deletion of either of these genes results in premature invasion of the cerebellar 
anlage by granule cells (Ma et al., 1998; Zou et al., 1998).  
Apart from studying the role of extracellular cues on neuronal migration in vivo their role on 
neuronal migration have also been studied in vitro. To this end, slice cultures were used to 
study endogenous cell migration with the possibility to supply chemoattractants, receptor 
blocking antibodies or other reagents, which might be involved in neuronal migration (Krull & 
Kulesa, 1998; Tucker, 2001). A more reductionist way of studying migration with respect to 
chemoattractants is the use of microchemotaxis chambers (Boyden chambers) (Richards & 
McCullough, 1984). In this method, a membrane separates the upper and the lower part of a 
chamber. Possible chemoattractants are placed in the wells of the lower compartment and 
cells are plated in the upper well. If the studied agent acts as a chemoattractant the cells 
from the upper well will migrate through the pores of the membrane towards the lower well. 
By applying such methods it could be shown that PDGF and VEGF are acting as a 
chemoattractant for FGF2 stimulated neural progenitors in vitro (Forsberg-Nilsson et al., 
1998; Zhang et al., 2003). 
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1.2.4. Neuronal migration defects in the CNS  
By analysing genetic mammalian brain malformations, several genes could be identified 
which are involved in the regulation of neural migration (Table 1.1), including Doublecortin 
(DCX), Filamin A and Reelin.  
 
Table 1.1: Overview of genes responsible for human congenital disorders featuring neuronal 
migration defects. Adopted from Ayala et al. (Ayala et al., 2007). 
 
 
 
The DCX gene was identified by positional cloning and is located on the X-chromosome. It 
encodes a 361 amino-acid protein that associates with and stabilizes microtubules, but 
shows no similarity to any classical microtubule associated protein (MAP) (Francis et al., 
1999; Gleeson et al., 1999; Taylor et al., 2000). DCX is specifically and abundantly 
expressed in neuronal progenitors of the developing and adult CNS (Chelly, 1998; des 
Portes et al., 1998; Gleeson et al., 1998; Francis et al., 1999; LoTurco, 2004; Rao & Shetty, 
2004; Couillard-Despres et al., 2005; Bernreuther et al., 2006). An evolutionary conserved 
domain is repeated in the N-terminal part of the protein and called the DC repeat. Each 
repeat alone is able to bind tubulin but neither is sufficient to mediate microtubule 
stabilization. Like classical MAPs, the interaction of DCX with the microtubules can be 
regulated by a number of different kinases (Schaar et al., 2004; Tanaka et al., 2004). The 
pathologies associated with DCX mutations are characterised by a disorganisation of the 
layers in the cerebral cortex also known as the “double-cortex” (Feng & Walsh, 2001), in 
which neurons accumulate inappropriately within the white matter beneath the normal cortical 
layers (Figure 1.8 c) or scattered across the cortical layers. Mutations in the DCX gene cause 
the “double-cortex” (subcortical laminar heterotopias) malformation in heterozygous carrier 
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women and the X-linked lissencephaly in males (Figure 1.8) (des Portes et al., 1998; 
Gleeson et al., 1999). Knockdown of the DCX expression by RNAi in adult rats confirmed the 
role of DCX in neuronal migration as affected cells accumulated in the white matter or 
scattered across the cortical layers compared to their normal position in the cortex of control 
animals (Bai et al., 2003). Overexpression of the wild-type DCX in neurons results in an 
increase in their migration rates of up to 30%. Further, this study indicated, that DCX in 
addition to its role in microtubule stabilisation, is also involved in dynein-driven nuclear 
translocation as DCX was also found in the neuronal soma and to associate with 
microtubules, which surround the nucleus (Tanaka et al., 2004).  
Biochemical and genetic evidence thus point to a role of DCX in crucial microtubule-based 
events in neuronal migration. However, which step of the migration process is affected in 
DCX mutantsʼ remains to be clarified.  
 
 
 
 
 
 
 
 
 
 
Figure 1.8: Pathologies associated with DCX mutations. MRI image of the cerebral cortex from (a) 
a human being, (b) a male patient and (c) a female patient with DCX mutation. Adopted from Feng et 
al. (Feng & Walsh, 2001). 
 
Studies in mice have identified additional mutant genes, which cause defects in the cortical 
structure. Among the most well known are Filamin A and Reelin (Marin & Rubenstein, 2003).  
Filamin A is an actin cross-linking protein that cooperates with members of the Arp2/3 
complex to form orthogonal actin networks. Filamin A is able to interact with a diverse group 
of transmembrane proteins and serves as a scaffold for signalling proteins of the Rho family 
of GTPases, which are also involved in neurite extension and in neuronal migration (Luo, 
2000; Dhavan & Tsai, 2001; Stossel et al., 2001). Mutations in the Filamin A gene cause 
periventricular heterotopias where neurons completely fail to migrate out of the germinal 
layers and instead form clusters that line the lateral ventricles of the brain (Figure 1.9 b) (Fox 
et al., 1998).  
 
  a b  c 
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When neurons reach their final destination and stop migrating, they continue to 
autonomously assemble into defined architectures. Observations in reeler mice show that the 
normal function of the reelin signalling pathway is essential for proper radial organization and 
layering of post migratory neurons at all levels of the CNS (Lambert de Rouvroit & Goffinet, 
1998). Reelin is a large glycoprotein (about 400 kDa) secreted by several neurons 
(D'Arcangelo et al., 1995) and binds to the VLDLR (very low-density lipoprotein receptor) and 
ApoER2 (ApoE receptor type 2). Both have a short cytoplasmatic tail that interacts with the 
tyrosine kinase adapter Dab1 (Disabled 1), which is expressed in the cytoplasm of migrating 
cortical neurons as a 555 amino-acid protein comprising an N-terminal phosphotyrosin-
binding (PTB) domain responsible for interacting with the lipoprotein receptors. Mutations of 
Reelin and Dab1 both generate a reeler phenotype (Howell et al., 1997; Sheldon et al., 1997; 
Ware et al., 1997), which is characterised by an abnormal lamination of the cerebral and 
cerebellar cortices including inversion of the normal “inside-out” pattern found in mammals 
(D'Arcangelo et al., 1995; Hirotsune et al., 1995) (Figure 1.9 d). A crucial importance of Dab1 
phosphorylation in neuronal positioning is demonstrated by the generation of Dab1 knock-in 
animals in which the fifth tyrosine residues have been replaced by phenylalanine. These 
mice display a similar phenotype to Dab1 null mutants (Howell et al., 2000).  
 
             
Figure 1.9: Schematic illustration of normal and different abnormalities of cortical 
development. (a) In the normal cortex, cells proliferate in the VZ and migrate along radial fibers. Early 
neurons settle horizontally in the marginal zone (MZ) (red) and subplate (pink). Early born neurons 
(green) and younger neurons (blue) demonstrate the so-called “inside-outside” gradient. (b) Mutations 
in the Filamin A cause periventricular heterotopias in which neurons cannot migrate from the VZ and 
settle locally. (c) In case of a DCX-mutation as occurs in type 1 lissencephaly, initial migration is 
satisfactory but many neurons settle at a subcortical level. (d) In the absence of Reelin signalling, 
cortical neurons (green) settle obliquely in the cortex. The next generation (blue) cannot cross the first 
one and the gradient is directed from outside to inside. Adopted from Lambert de Rouvroit & Goffinet 
(Lambert de Rouvroit & Goffinet, 2001). 
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1.3. Objectives of this study 
The main goal of this project was to establish a new lineage selection protocol in order to 
generate pure cultures of immature neurons from human ES cells. To that end a reporter 
construct carrying the human Doublecortin (DCX) promoter and a fluorescent marker gene 
had to be introduced into long term proliferating human ES cell-derived neural stem cells (lt-
hESNSC). As a prerequisite a detailed analysis of the endogenous DCX expression during 
the time course of neural differentiation and terminal maturation had to be performed. After 
finding appropriate transfection methods for lt-hESNSC the faithful expression of the 
fluorescent marker in differentiating lt-hESNSC had to be validated by comparison to the 
endogenous DCX expression level. Time period of differentiation as well as procedures for 
the fluorescent activated cell sorting (FACS) of DCX-EGFP-positive neurons had to be 
developed in order to achieve maximum post-FACS survival rates. Following 
immunocytochemical characterization electrophysiological properties of selected neurons 
including single cell patch clamp analyses had to be performed to analyse the influence of 
the selection procedure on the functional characteristics of the cells. In order to facilitate 
conservation of selected neurons the aim was to develop cryopreservation procedures 
enabling long-term storage of human neurons.  
 
A second major aim of this study was to characterise the migratory properties of DCX-EGFP-
selected neurons in vitro and in vivo. In vivo, expression of DCX is closely associated with a 
migratory phenotype. Consequently, the migratory capacity of DCX-EGFP selected neurons 
had to be explored in vitro (e.g. transwell filter assays), on hippocampal slice cultures as well 
as after transplantation into different regions of the adult rodent brain. A particular aspect 
was to compare the properties of a selected pure neuronal population with a mixed cell 
population containing neurons as well as neural stem/progenitor cells. These studies should 
provide insight into potential paracrine effects between neural stem/progenitor cells and early 
neurons in the graft.  
 
Thus, the focus of this study was to develop a technology to generate large numbers of 
immature human ES cell derived neurons, to use these cells to study migration and 
integration of transplanted neural populations and to find ways to enhance the integration 
potential of human ES cell derived neurons for neural cell replacement. 
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2. MATERIALS 
Cell culture plastic ware including dishes, centrifugation tubes, cell strainer, cell scraper and 
incubation tubes were obtained from BioRad Laboratories (Munich, Germany), Corning 
Coster (New York, USA), Eppendorf (Hamburg, Germany), Falcon/Becton Dickinson 
(Heidelberg, Germany), Greiner (Nürtingen, Germany), Millipore (Billerica, USA) and Nunc 
(Wiesbaden, Germany). Glass materials were obtained from Schott (Mainz, Germany).  
 
2.1.  Technical equipment 
Appliance Name Manufacturer Registered office 
Autoclave D-150 Systec Wettenberg, Germany 
Balance BL610 Sartorius Göttingen, Germany 
Balance LA310S Sartorius Göttingen, Germany 
Block heater Thermomixer compact Eppendorf Hamburg, Germany 
Capillary Capillary GB150T Science Products Hofheim, Germany 
Cell culture centrifuge Megafuge 1.0R Kendro Hanau, Germany 
Counting chamber Fuchs-Rosenthal Faust Halle, Germany 
Cryostat Cryostat HM 560 Microm Laborgeräte Walldorf, Germany 
Digital camera C 5050 Zoom Olympus Optical Hamburg, Germany 
Digital camera Canon Power Shot G5 Canon  Krefeld, Germany 
FACS® sorter FACS® DiVa BD Biosciences San Jose, USA 
Fluorescence lamp HAL100 Carl Zeiss Hamburg, Germany 
Fluorescence lamp Fluo-Lamp U-RFL-T Olympus Jena, Germany 
Freezer -80°C HERAfreeze Kendro Hanau, Germany 
Freezing container NamgeneTMCryo 1°C Nalge Nunc New York, USA 
Glass-Microelectrode 
Puller  PE-21 Tritech Research Los Angeles, USA 
Gel chamber Agagel Biometra Göttingen, Germany 
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Appliance Name Manufacturer Registered office 
Incubator HERAcell Kendro Hanau, Germany 
Inverse light microscope Axiovert 25 Carl Zeiss Jena, Germany 
Liquid nitrogen store MVE 611 Chart Industries Burnsville, USA 
Micro Drill High Speed Micro Drill Fine Science Tools Heidelberg, Germany 
Microliterpipet Microliterpipet 1710N Hamilton Bonaduz, Switzerland 
Microscope Axiovert 40 CFL Carl Zeiss Jena, Germany 
Microscope Axiovert 200M Carl Zeiss Jena, Germany 
Microscope Axioskop 2 Carl Zeiss Jena, Germany 
Microscope ApoTom Carl Zeiss Jena, Germany 
Microscope IX 81 Confocal Olympus Hamburg, Germany 
Microscope Imager Z 1 Carl Zeiss Jena, Germany 
Microscope camera Axiocam MRM Carl Zeiss Jena, Germany 
Microscope camera ProgRes C14 Jena Optic Jena, Germany 
Microscope laser Laser Mells Griot Laser Mells Griot Lasergroup Carlsbad, Germany 
Microscope slides  Superfrost plus Menzel-Gläser Braunschweig, Germany 
Nucleofector Nucleofector TM Amaxa Cologne, Germany 
Plastic coverslips Thermanox®plastic coverslips Nunc Wiesbaden, Germany 
PCR cycler T3000 Termocycler Biometra Göttingen, Germany 
pH-meter CG840 Schott Mainz, Germany 
Pipetteboy Accu-Jet Brand Wertheim, Germany 
Polyester membrane Transwell-Clear Corning Bodenheim, Germany 
Power supply  Standard Power Pack P25 Biometra Göttingen, Germany 
Refrigerators/Freezers 
4°C and -20°C G 2013 Comfort Liebherr Lindau, Germany 
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Appliance Name Manufacturer Registered office 
Shaker Bühler Schüttler WS 10 Johanna Otto Hechingen, Germany 
Sterile laminar flow hood HERAsafe Kendro Hanau, Germany 
Stereo microscope STEMI 2000-C Carl Zeiss Göttingen, Germany 
Stereotactic Frame Stereotactic Frame Stoelting Illinois, USA 
Sterilizer Compact Hot Bead Sterilizer Fine Science Tolls Heidelberg, Germany 
Thermocycler T3 Thermocycler Biometra Göttingen, Germany 
Table centrifuge Centrifuge 5415R Eppendorf Hamburg, Germany 
Transplantation tool Micromanipulator Self-made Bonn, Germany 
Transplantation tools Transplantation Tool Set Fine Science Tools Heidelberg, Germany 
Transwell Millicell, 8 µm Millipore Billerica, USA 
UV-Vis 
Spectrophotometer BioPhotometer Eppendorf Hamburg, Germany 
Vacuum pump Vacuubrand Brand Wertheim, Germany 
Vibroslicer VSLM1 Campden Instruments Sileby, GB 
Water bath 1008 GFL Burgwedel, Germany 
 
2.2.  Chemicals and reagents 
Chemicals Manufacturer Registered office 
2-Mercaptoethanol Invitrogen Karlsruhe, Germany 
Adenosine 3ʼ, 5ʼ-Cyclic 
monophosphate Sigma Deisenhofen, Germany 
Affi-Gel®Blue-Gel BioRad Munich, Germany 
Agar Sigma Deisenhofen, Germany 
Agarose PEQLAB Erlangen, Germany 
Ampicillin Sigma Deisenhofen, Germany 
   Materials 
 
24 
Chemicals Manufacturer Registered office 
Apo-Transferrin Millipore Schwalbach, Germany 
Ascorbic acid Sigma Deisenhofen, Germany 
B27 supplement Invitrogen Karlsruhe, Germany 
BDNF R&D Systems Wiesbaden, Germany 
Bromphenol blue Sigma Deisenhofen, Germany 
BSA Sigma Deisenhofen, Germany 
Collagenase type IV Invitrogen Karlsruhe, Germany 
Cyclosporine Novartis Nürnberg, Germany 
CytoconTMBuffer II Evotec Technologies Hamburg, Germany 
DMEM, high glucose Invitrogen Karlsruhe, Germany 
DMEM/F12 (1:1) Invitrogen Karlsruhe, Germany 
DNA ladder (100bp) Fermentas Leon-Rot, Germany 
DNA loading buffer (6 x) Fermentas Leon-Rot, Germany 
DNase (cell culture) CellSystems St. Katharinen, Germany 
dNTPs PEQLAB Erlangen, Germany 
DMSO Sigma Deisenhofen, Germany 
EDTA Sigma Deisenhofen, Germany 
EGF R&D Systems Wiesbaden, Germany 
Endostatin Sigma Deisenhofen, Germany 
Ethanol Merk Darmstadt, Germany 
Ethidium bromide Sigma Deisenhofen, Germany 
FCS Invitrogen Karlsruhe, Germany 
FGF2  R&D Systems Wiesbaden, Germany 
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Chemicals Manufacturer Registered office 
Forskolin Sigma Deisenhofen, Germany 
Freezing medium, serum free Sigma Deisenhofen, Germany 
G418 PAA Laboratories Cölbe, Germany 
Gelatine Invitrogen Karlsruhe, Germany, Germany 
Glucose Sigma Deisenhofen, Germany 
Glycerol Sigma Deisenhofen, Germany 
Heparin sodium salt Sigma Deisenhofen, Germany 
Horse serum Invitrogen Karlsruhe, Germany 
Insulin Sigma Deisenhofen, Germany 
Isopropanol Sigma Deisenhofen, Germany 
Ketanest Parke Davis Karlsruhe, Germany 
L-Glutamine Invitrogen Karslruhe, Germany 
Laminin Sigma Deisenhofen, Germany 
Matrigel, not growth factor 
reduced BD Bioscience Heidelberg, Germany 
MgCl2 Invitrogen Karslruhe, Germany 
Mowiol 4-88 Merck Darmstadt, Germany 
Myo-inositol Sigma Deisenhofen, Germany 
N2 supplement Invitrogen Karslruhe, Germany 
NaHCO3 Sigma Deisenhofen, Germany 
Neurobasal medium Invitrogen Karslruhe, Germany 
Non-essential amino acids Invitrogen Karlsruhe, Germany 
NucleofectorTMSolution T8352 Amaxa Cologne, Germany 
Paraformaldehyde Sigma Deisenhofen, Germany 
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Chemicals Manufacturer Registered office 
PBS Invitrogen Karlsruhe, Germany 
PDGF-AA R&D Systems Wiesbaden, Germany 
Poly-l-ornithine Sigma Deisenhofen, Germany 
Polyvinyl-alcohol 72000 Merck Darmstadt, Germany 
Progesterone Sigma Deisenhofen, Germany 
Putrescine Sigma Deisenhofen, Germany 
Propidium iodide Sigma Deisenhofen, Germany 
Reverse transcriptase Roch Mannheim, Germany 
Rompun Parke Davis Karlsruhe, Germany 
Serum replacement Invitrogen Karlsruhe, Germany 
Sodium azide Sigma Deisenhofen, Germany 
Sodium pyruvate Invitrogen Karlsruhe, Germany 
Sodium selenite Sigma Deisenhofen, Germany 
Staurosporine Sigma Deisenhofen, Germany 
Taq DNA polymerase  Invitrogen Karsruhe, Germany 
Tris Merck Darmstadt, Germany 
Triton-X-100 Sigma Deisenhofen, Germany 
Trypan blue Invitrogen Karlsruhe, Germany 
Trypsin-EDTA  Invitrogen Karlsruhe, Germany 
Trypsin-inhibitor Invitrogen Karlsruhe, Germany 
Vectashield®mounting medium Axxora Loerrach, Germany 
VEGF 165 R&D Systems Wiesbaden, Germany 
Z-VAD-fmk R&D Systems Wiesbaden, Germany 
 
   Materials 
 
27 
2.3.  Cell lines and animal stocks 
Primary embryonic fibroblasts  mouse strain CD1 
Human ES cell line H9.2  Haifa, Israel (Amit et al., 2000) 
Fox Chase Scid/Beige mice  Charles River, Sulzfeld, Germany 
Sprague-Dawley rats   Charles River, Sulzfeld, Germany 
 
2.4.  Plasmids 
The phu-DCX3509-EGFP (Karl et al., 2005) plasmid encodes the reporter gene EGFP under 
the control of the human DCX-promoter cloned into the SmaI-linearised promoterless 
pEGFP-N1 vector (BD/Clontech, Heidelberg, Germany). The phu-DCX3509-DsRED2 (Karl et 
al., 2005) plasmid encodes the reporter gene pDsRED2 under the control of the human DCX-
promoter cloned into the SmaI-linearised promoterless DsRED2 vector (BD/Clontech, 
Heidelberg, Germany). Both plasmids were kindly provided by Sebastien Couillard-Després 
and Ludwig Aigner. 
Length: 7,6 kb; Resistance genes: Kanamycin, Neomycin 
 
 
 
 
 
Figure. 2.1: Plasmid phu-DCX3509-EGFP and phu-DCX3509-DsRED2, human DCX promoter 
(hDCX), polyadenylation consensus sequence of the Simian Virus 40 (SV40polyA), 
Kanamycin/Neomycin resistance (Kan/Neo R+).  
 
2.5.  Cell culture reagents 
2.5.1. Cell culture stock solutions 
Reagent Concentration Solvent 
Adenosine 3ʼ, 5ʼ-Cyclic monophosphate 100 µg/ml H2O 
Ascorbic acid 100 mM H2O 
BDNF 10 µg/ml Diluted acetic acid + 0.1% BSA 
Endostatin 4 mg/ml 17 mM citric-phosphate buffer, pH 6.2 
EGF 10 µg/ml Diluted acetic acid + 0.1% BSA 
FGF2 10 µg/ml PBS + 0.1% BSA 
G418 50 mg/ml H2O 
GDNF 10 µg/ml Diluted acetic acid + 0.1% BSA 
Heparin 2 mg/ml H2O 
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Reagent Concentration Solvent 
Insulin 5 mg/ml 10 mM NaOH 
Myo-inositol 500 mM H2O 
PDGF 10 µg/ml Diluted HCl + 0.1% BSA 
Polyvinyl-alcohol 50 mg/ml H2O 
Progesterone 20 µM Ethanol 
Putrescine 0.1 M H2O 
Sodium selenite 500 µM H2O 
SU5402 20 mM DMSO 
Transferrin  10 mg/ml H2O 
VEGF 20 µg/ml PBS + 0.1% BSA 
VEGF R2 (KDR) Antibody 100 µg/ml PBS + 0.1% BSA 
Z-FAD-fmk 50 mM DMSO 
 
2.5.2. Cell culture media 
Mouse embryonic fibroblast (MEF) medium 
87%  DMEM 
10%  FCS, heat inactivated 
1%  Sodium pyruvate (stock: 100 mM) 
1%  Non-essential amino acids (stock: 10 mM) 
1% L-glutamine (stock: 200 mM) 
 
Knockout/Serum replacement (KO/SR) medium 
79%   KO-DMEM 
20%  SR 
1%  Non-essential amino acids (stock: 10 mM) 
1 mM   L-glutamine 
0.1 mM  β-Mercaptoethanol 
4 ng/ml  FGF2 
 
Embryoid body (EB) medium 
79%  KO-DMEM 
20%  SR 
1%  Non-essential amino acids (stock: 10 mM) 
1 mM  L-glutamine 
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ITSFn medium 
5 µg/ml  Insulin    
50 µg/ml  Apo-transferrin  
30 nM  Sodium-selenite   
30 nM  Human fibronectin 
in DMEM/F12 
 
Neural stem cell (NSC) medium 
500 ml  DMEM/F12, high glucose 
5 ml   N2 supplement 
1.68 mg Glucose 
20 µg/ml Insulin  
 
Neuronal generation (NGc) medium 
50%   NSC medium 
48%   Neurobasal medium   
2%  B27 supplement 
100 ng/ml cAMP 
 
Neuronal precursor freezing medium (NP-FM) 
10%   DMSO  
20%  Myo-inositol (stock: 500 mM) 
5%  Polyvinyl alcohol (stock: 50 ng/ml) 
65%   SR 
 
2.5.3. Cell dissociation reagents 
Collagenase type IV (1 mg/ml) 
50 mg   Collagenase type IV 
50 ml   KO/SR medium 
 
Trypsin-EDTA (1 x) 
90%   PBS 
10%   10 x Trypsin-EDTA  
mixed and stored at -20°C. 
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2.5.4. Coating materials 
Poly-l-ornithin (PO) 
100 x stock solution: 
100 mg  PO 
67 ml   dH2O 
sterile filtered and stored at -20°C 
working dilution: 
5 ml   100 x stock solution 
495 ml  dH2O 
sterile filtered and stored at 4°C 
 
Gelatine (0.1%) 
1 g  Gelatine powder type A 
1 l  dH2O 
autoclaved and stored at room temperature.  
 
Laminin (LN) 
1 µg/ml Human laminin  
in PBS, mixed and stored at 4°C 
 
Matrigel 
1 ml  Matrigel stock solution 
29 ml  DMEM/F12 
The matrigel stock solution is thawed overnight at 4°C. A 2 ml pipette is cooled in the -20°C 
freezer to avoid attachment of the matrigel. 1 ml of matrigel stock solution is pipetted quickly 
to 29 ml cooled DMEM/F12. The dilution is stored at 4°C. 
 
2.5.5. FACS solutions  
500 µl  DNAse (stock: 1%) 
100 ml  CytoconTMBuffer II 
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2.6.  Reagents for immunohistochemistry  
PBS-azide (0.1%) 
1 g  Sodium-azide 
1 l  PBS    
stored at room temperature 
 
Fixation solution (4% Paraformaldehyde, PFA) 
40 g   PFA  
1 l   PBS (warmed) 
mix to dissolve and adjust pH to 7.4; Cooled on ice and stored at -20°C. 
 
Blocking solution 
10%  FCS  
90% PBS-azide.  
For the staining of intracellular markers 0.1% triton is added. The blocking solution is 
prepared freshly before use. 
 
Borate buffer (0.1 M, pH 8.5) 
3.8 g   Sodium borate (MW 381.4) 
100 ml  H2O 
mix to dissolve and adjust pH to 8.5 
 
Mowiol 
6 g   Glycerol 
2.49 g  Mowiol 
in 6 ml  H2O 
12 ml  Tris-HCL (0.2 M, pH 8.5)  
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2.6.1. Primary antibodies 
ms = mouse, rb = rabbit, gt = goat 
Epitope and origin Dilution Manufacturer 
A2B5 (ms) IgM 1:500 Chemicon 
BrdU (ms) IgG 1:33 Becton Dickinson 
GABA (rb) 1:1000 Sigma 
Gad67 (rb) 1:200 Chemicon 
GFP (rb) 1:2000 Abcam 
GFAP (ms) IgG 1:100 ICN Biomedicals  
GFAP (rb) 1:1000 DAKO 
hDCX (gt) IgG 1:200 Santa Cruz 
hNestin (ms) IgG 1:600 R&D Systems 
hSynaptophysin (ms) IgG 1:1000 Chemicon 
hNuc (ms) IgG 1:200 Chemicon 
Ki67/MIB1 (ms) IgG 1:250 DAKO 
MAP2ab (ms) IgG 1:500 Chemicon 
NeuN (ms) IgG 1:100 Chemicon 
O4 (ms) IgM 1:200 R&D Systems 
PSA-NCAM (ms) IgM 1:500 Chemicon 
Serotonin (rb) 1:800 Sigma 
β-III-tubulin (ms) IgG 1:600 Covance 
β-III-tubulin (rb) 1:2000 BAbCo 
S100β (ms) IgG 1:2000 Sigma 
TH (ms) IgG 1:800 Sigma 
 
2.6.2. Secondary antibodies 
Epitope and coupled dye Dilution Manufacturer 
anti-mouse, Cy3 1:500 Dianova / Jackson ImmunoResearch 
anti-mouse, FITC 1:200 Dianova / Jackson ImmunoResearch 
anti-rabbit, Cy3 1:500 Dianova / Jackson ImmunoResearch 
anti-rabbit, FITC 1:500 Dianova / Jackson ImmunoResearch 
anti-goat, FITC 1:500 Dianova / Jackson ImmunoResearch 
anti-mouse, Cy5 1:500 Dianova / Jackson ImmunoResearch 
anti-rabbit, Cy5 1:500 Dianova / Jackson ImmunoResearch 
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2.7. Reagents for molecular biology 
50 x Tris-acetate-buffer (TAE) 
242 g   Tris (dissolved in 500 ml H2O) 
100 ml  EDTA (0.5 M, pH 8.0) 
57.1 ml  Glacial acetic acid 
volume is adjusted to 1 litre with H2O and stored at room temperature 
 
1 x TAE 
50 x TAE is diluted 1:50 with H2O and stored at room temperature. 
 
10 x Sample buffer 
70%  Tris, (100 mM, dissolved in H2O, pH 8.0)  
29.2%  Glycerol 
0.4%   Bromphenol blue 
0.4%   Xylene cyanol 
mixed and stored at 4°C. 
 
2.7.1. Primers 
Name Primer Sequence 
BDNF Fw: 5′-gccctgtatcaacccagaaa-3′ Rv: 5′-cttcagaggccttcgttttg-3′ 
cKit Fw: 5′-ctatgctctcgcacctttcc-3′ Rv: 5′-caatgaagtgcccctgaagt-3′ 
CXCR4 Fw: 5′-ggtggtctatgttggcgtct-3′ Rv: 5′-tggagtgtgacagcttggag-3′ 
EGF Fw: 5′-cagggaagatgaccaccact-3′ Rv: 5′-cagttcccaccacttcaggt-3′ 
EGFR Fw: 5′-taacaagctcacgcagttgg-3′ Rv: 5′-gttgagggcaatgaggacat-3′ 
FGF2 Fw: 5′-gacaggcctcctggaaactt-3′ Rv: 5′-gagggagaaaggatggaagc-3′ 
FGFR1 Fw: 5′-gcgagggtcagtttgaaaag-3′ Rv: 5′-gtgcagagtgtggctgtgac-3′ 
FGFR2 Fw: 5′-ttacgaaccatgccttcctc-3′ Rv: 5′-ttctcctcctggggaagatt-3′ 
FGFR3 Fw: 5′-gtgtgcaggttccgatgtta-3′ Rv: 5′-caactgaattcacggcttcc-3′ 
FGFR4 Fw: 5′-cctccagcgattctgtcttc-3′ Rv: 5′-catgctatcaaggtcgagca-3′ 
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Name Primer Sequence 
FLK/KDR Fw: 5′-ggcttgtgacccaagaatgt-3′ Rv: 5′-gcaaatccttcccatcttca-3′ 
FLT1 Fw: 5′-aagggaagaccccgtctcta-3′ Rv: 5′-gccagctaatgctcttccac-3′ 
FLT4 Fw: 5′-catcatgctgaactgctggt-3′ Rv: 5′-gagaagctgccctcttctga-3′ 
GAPDH Fw: 5′-acgaccccttcattgacctcaact-3′ Rv: 5′-atatttctcgtggttcacacccat-3′ 
NRP1 Fw: 5′-gaagcaccgagagaacaagg-3′ Rv: 5′-ctcggggtagatcctgatga-3′ 
PDGFA Fw: 5′-acacgagcagtgtcaagtgc-3′ Rv: 5′-cctcacatccgtgtcctctt-3′ 
PDGFB Fw: 5′-aagcacacgcatgacaagac-3′ Rv: 5′-gacggacgagggaaacaata-3′ 
PDGFC Fw: 5′-ggaggcctaaaggacaggag-3′ Rv: 5′-ttaagcaaggcaacggaatc-3′ 
PDGFD Fw: 5′-atggcatgggcattctgtat-3′ Rv: 5′-cgggaacacaaaagcaagat-3′ 
PDGFRα Fw: 5′-ctgggtttccatccttgaga-3′ Rv: 5′-tagtaggcttcctgcgtggt-3′ 
PDGFRβ Fw: 5′-gcacttttatccacccagga-3′ Rv: 5′-gtacttggctcagcctccag-3′ 
ß-Aktin Fw: 5′-gaagagctacgagctgcc-3′ Rv: 5′-tgatccacatctgctgga-3′   
TrkB Fw: 5′-tcaacaaatgtggacggaga-3′ Rv: 5′-gtggtgaacacaggcatcac-3′ 
VEGF Fw: 5′-cagctactgccgtccaatcg-3′   Rv: 5′-tcaccgcctcggttgt-3′  
 
 
2.7.2. Kits 
Name Producer Registered office 
ApopTag® Fluorescence Direct In Situ 
Apoptosis Detection Kit 
Chemicon  Temecula, USA 
iScriptTMcDNA Synthesis Kit BioRad Munich, Germany 
PureYieldTM  
Plasmid Midiprep System 
Promega GmbH  Mannheim, Germany 
peqGOLD  
Plasmid Miniprep Kit I 
Peqlab Biotechnologie GmbH Erlangen, Germany 
QIAquick PCR Purification Kit QIAGEN GmbH Hilden, Germany 
RNeasy®Mini Kit QIAGEN GmbH Hilden, Germany 
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2.8.  Software 
Name Application Producer 
AxioVs40LE 4.5.0.0 Fluorescence microscopy Carl Zeiss 
BD FACSDiva Software FACSorter BD Bioscience 
Openlap 4.0 Fluorescence microscopy Jena Optic 
Quantity One Electrophoresis gel documentation Bio-Rad 
Mac OS X Software Microsoft office for Mac Macintosh 
   Methods 
 
36 
3. METHODS 
3.1.  Cultivation of pluripotent hES cells 
Generally, cell culture was performed under sterile conditions in a sterile hood with sterile 
media, glass and plastics. Cells were cultivated in an incubator at 37°C, 5% CO2 and 
saturated air humidity. 
 
3.1.1. Generation, cultivation and mitotic inactivation of murine fetal fibroblasts 
All working steps were performed according to the standard operation procedures of the 
Institute of Reconstructive Neurobiology, University of Bonn. 
 
3.1.2. Cultivation of hES cells 
HES cells were cultivated on a layer of irradiated mouse fibroblasts (MEF). Cells were grown 
in serum-free KO/SR medium. Medium was changed daily and hES cells were passaged 
about every four days. For passaging, medium was removed and the cells were incubated in 
1 mg/ml collagenase IV for one hour. Subsequently, cells were rinsed off, pipetted up and 
down to obtain small clusters and centrifuged in a 15 ml centrifugation tube (800 rpm, 3 min, 
4°C). The cells were plated at a ratio of 1:4 on fresh MEF.  
Morphologically differentiated hES cells were manually removed by scraping with a sterile 
injection needle (26 g 3/8, 0.45 x 10) in a horizontal sterile hood using a microscope. 
Subsequently, differentiated colonies were removed together with the KO/SR medium.  
 
3.2.  In vitro differentiation of hES cells into lt-hESNSC 
In vitro differentiation of hES cells into long term proliferating hES-derived neural stem cells 
(lt-hESNSC) was performed as described (Zhang et al., 2001; Li et al., 2005; Koch et al., 
2006).  
For the generation of embryoid bodies (EBs), hES cells were detached as described (3.1.2). 
The pellet was re-suspended only 5 x with a 5 ml-pipette to preserve the colonies. 
Aggregates were transferred into 6 cm bacterial dishes to avoid adherence. Medium was 
changed every other day by transferring the EBs to a 15 ml centrifugation tube. After 
sedimentation of the aggregates, the supernatant was replaced with fresh EB medium. Four-
day-old EBs were transferred to poly-l-ornithine coated tissue culture dishes and propagated 
in ITSFn medium with 20 ng/ml FGF2. Within 10 days, neural tube-like structures developed 
in the EB outgrowth. These structures were mechanically isolated and propagated as free-
   Methods 
 
37 
floating neurospheres in NSC medium containing 10 ng/ml FGF2 for 1-3 weeks. 
Neurospheres were triturated into single cells by incubating them with trypsin/EDTA for 10 
min in a 15 ml centrifugation tube. Trypsin was inhibited by trypsin inhibitor. Cells were 
pipetted up and down to obtain single cells and centrifuged (1000 rpm, 5 min, 4°C). Single 
cells were plated on poly-l-ornithine/laminin coated plastic dishes. Medium was changed to 
NSC medium containing 10 ng/ml FGF2, 10 ng/ml EGF and 1 µl/ml B27 supplement (Figure 
3.1).  
 
Figure. 3.1: In vitro differentiation of hES cells into lt-hESNSC. To induce differentiation, hES cells 
were aggregated to form free-floating EBs. Neural tube-like structure formation was induced in the EB 
outgrowth upon plating and a four-day cultivation in ITSFn medium. These structures became visible 
(see red arrow) in the expanded cultures. They were mechanically isolated and further propagated as 
neurospheres. Neurospheres were triturated into single cells, which were replated and further 
cultivated as stably proliferating lt-hESNSC in NSC medium. 
 
Daily media change was performed for the first 7 days. Cells were passaged every 2-4 days 
at a 1:2 to 1:3 ratio by incubating the cells in the tissue culture dish with trypsin/EDTA. 
Trypsin was inhibited by trypsin inhibitor and cells were centrifuged in a 15 ml centrifugation 
tube (1000 rpm, 5 min, 4°C). Replating densities were kept above 30%. Terminal 
differentiation was performed by growth factor withdrawal in NGc medium. For storage 
trypsinized lt-hESNSC were resuspended in 1ml freezing medium (Sigma). Cells were 
directly transferred in a NalgeneTMCryo 1°C freezing container and placed at −80°C to 
achieve a 1°C/min rate of cooling. Final temperature was reached after freezing in liquid 
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nitrogen. Thawing was carried out by gently swirling the cryo-vial in a 37°C water bath for 1.5 
min. After thawing, the cells were quickly placed into DMEM/F12 medium in a 15 ml 
centrifugation tube and centrifuged (800 rpm, 6 min, 4°C). The supernatant was discarded 
and the pellet was carefully re-suspended in 2 ml NSC medium containing 10 ng/ml FGF2, 
10 ng/ml EGF and 1 µl/ml B27 supplement with a 5 ml pipette before transferring it to PO/LN 
coated culture dishes. 
 
3.3.  Stable nucleofection of lt-hESNSC  
Lt-hESNSC were stably transfected by nucleofection (Amaxa - nucleofection program B0-33/ 
B0-16) with the phuDCX3509-EGFP or the phuDCX3509-DsRED2 vector (Couillard-Despres 
et al., 2005). Three million lt-hESNSC were trypsinized and centrifuged (1000 rpm, 5 min 
4°C). 3 µg DNA was added to the cell pellet. The pellet was incubated for 1 min following 
resuspension in 100 µl NucleofectorTMSolution before cells were transferred into a 
nucleofection cuvette. The cuvette was inserted into the NucleofectorTM and the appropriate 
cell-type specific program (B0-33 or B0-16 for lt-hESNSC) was chosen before starting 
nucleofection. The sample was removed from the cuvette immediately after nucleofection 
and transferred to a PO/LN coated culture dish. The cells were subsequently selected for 
gentamycin resistance by adding 50 µg/ml G418 into NSC medium containing 10 ng/ml 
FGF2, 10 ng/ml EGF and 1 µl/ml B27 supplement. Emerging colonies were manually 
removed, replated and further propagated. Recapitulation of DCX expression by the EGFP or 
by the DsRED2 reporter was confirmed via immunocytochemistry after 6 days of cultivating 
the cells in NGc medium to induce differentiation. 
 
3.4.  Fluorescence activated cell sorting 
FACS DiVa was used for flow cytometric cell sorting. Lt-hESNSC stable expressing EGFP or 
DsRED2 under the hDCX promoter, cultured in NGc medium for 8±1 days were trypsinized, 
gently resuspended in Cytocon™Buffer II (Evotec) containing 0.5% DNase  (Invitrogen) and 
filtered through a 40 µm nylon mesh (Pall GmbH). The cells were sorted at a concentration of 
3 million cells/ml on a fluorescence-activated cell sorter FACS DiVa (Becton Dickinson) using 
FACS Diva software (BD Bioscience). Cells were selected by forward-angle and sideward-
angle light scatter and for EGFP or DsRED2 fluorescenceʼs intensity, with an argon-ion laser 
(Coherent) operating at 488 nm. Purity of the sorted fractions was analysed by FACS 
reanalysis and by immunocytochemistry following replating. Prior to sorting the nozzle, 
sheath and sample lines were sterilized with 70% ethanol followed by washing with sterile 
water. A 70 µm ceramic nozzle (BD Bioscience), sheath pressure of 20 to 25 pounds per 
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square inch (PSI) and an acquisition rate of 2000 to 3000 events/sec was used as conditions 
optimized for cell sorting of immature neurons. 
 
3.5. Preparation of primary astrocytes 
Primary astrocytes were prepared according to the protocol from Polleux and Glosh (Polleux 
et al., 2002). Mouse pups from postnatal day 3 (P3) were anesthetized and decapitated. The 
preparation of the brains was performed in 6 cm petri dishes, using a stereomicroscope 
under a sterile laminar flow hood. The brains were removed and rinsed in PBS containing 2% 
glucose. The specimens were incubated in 3 ml 10 x trypsin at 37°C for 3 minutes and rinsed 
again. Then MEF medium and 500 µl DNase (1%) were added to a total volume of 5 ml. The 
tissue was triturated to a cell suspension with a 1000 µl pipette. Finally, the cells were filtered 
through a nylon mesh (40 µm) and centrifuged for 10 min at 1000 rpm. 2.5 to 5 x 106 cells 
were plated on PO/LN coated 10 cm dishes in MEF medium. A confluent astrocyte cell layer 
appeared after 5 to 10 days. 
 
3.5.1. Direct-/ in-direct shared media culture with primary astrocytes 
For direct co-culture primary astrocytes were plated on PO/LN coated plastic coverslips and 
cultivated at least for 24 hours before plating purified human neurons on top of the primary 
astrocyte layer. For in-direct co-culture purified human neurons were plated on PO/LN coated 
12 well culture dish. In parallel, primary astrocytes were plated on PO/LN coated transfilter 
membrane (4 µm pore size), which can be hooked into a 12 well culture dish. Both cell types 
were cultured for 24 hours before assembling. 
3.6. Cryopreservation of purified human neurons  
Purified neurons were centrifuged in batches of 5 million cells (1000 rpm, 5 min, 4°C). 
Treatment with the general caspase inhibitor z-VAD-fmk was performed in the cell solution 
30 minutes before freezing in a 500 nM concentration. The cell suspension was frozen with 
1.5 ml freezing medium containing 10% DMSO, 20% 500 mM myo-inositol, 5% polyvinyl 
alcohol stock solution and 65% KnockoutTMSerum-Replacement. Cells were directly 
transferred in a NalgeneTMCryo 1°C freezing container and placed at -80°C to achieve a 
−1°C/min rate of cooling. Final temperature was reached after freezing in liquid nitrogen. 
Thawing was carried out by gently swirling the cryo-vial in a 37°C water bath for 1.5 min. 
After thawing, the cells were quickly transferred into DMEM/F12 medium in a 15 ml-
centrifugation tube and centrifuged (800 rpm, 6 min, 4°C). The supernatant was discarded, 
and the pellet was carefully re-suspended in 2 ml NGc medium with a 5 ml-pipette. Survival 
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rates were obtained using standard trypan blue exclusion test. Caspase-3/7 activity was 
measured in a luminescent assay (Caspase-Glo®3/7Assay) according to the manufacturerʼs 
instruction 20 hours after thawing and replating of purified cryopreserved immature neurons. 
 
3.7. In vitro migration assays 
3.7.1. Transwell migration assay 
One way to study migration at the cellular level is to use microchemotaxis chambers (Boyden 
chambers) (Richards & McCullough, 1984). A membrane separates the upper and the lower 
part of the chamber. Cells are plated on the PO/LN coated membrane that separates the 
upper and the lower well. Chemoattractants are introduced in the well of the lower 
compartment e.g., by soaking agarose beads (affi-gel blue gel) with the corresponding 
chemoattractants. 100 µl of the pre-soaked beads are introduced in the lower well and 
covered with medium before placing the upper well on top. The chemoattractant will be 
released over time, thus creating a chemoattractive gradient. If the agent acts as a 
chemoattractant, the attached cells will migrate through the filter towards the gradient of the 
attracting factor. Small pore sizes (8 µm) require active migration rather than passive falling 
of the cells through the filter. 
In this study agarose beads were soaked with either 30 ng/ml EGF, BDNF, SDF1, SCF, 
PDFG-AA, FGF2 or VEGF (see 2.5.1 for stock solutions). The chemoattractive effect of 
NSCs on neurons was studied by plating lt-hESNSC directly in the PO/LN coated lower well 
before placing the upper well with the attached neurons on top. After a culture period of 20 
hours, chambers were fixed with 4% PFA for 10 min. Cells that had not migrated and were 
still on the upper side of the membrane were scraped off, while the migrated cells on the 
lower side were DAPI stained and counted (Figure 3.2).  
 
 
 
 
 
 
Figure 3.2: Cell migration studied by using a chemotaxis chamber. Cells are plated on the 
membrane of the upper well. Chemoattractants can be added to the lower well. Migration of cells from 
the upper well through the membrane can be measured by scraping off the remaining cells from the 
upper side of the membrane and counting the cells that reached the bottom side. Adopted from 
Erlandsson (Erlandsson, 2003). 
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3.7.2. Matrigel migration assay 
Matrigel matrix is a soluble basement membrane extract. The major components of matrigel 
matrix are collagens, laminin and proteoglycans. It can provide the substrate necessary for 
the study of cell migration. For the matrigel migration assay the matrigel matrix was thawed 
at 4°C overnight and diluted at a ratio of 1:2 in cold DMEM/F12 medium. Per well of a 4-well-
plate 250 µl of the matrigel matrix mixture was added and incubated at 37°C for at least 30 
minutes for hardening. Cells were spotted (1 µl cell suspension containing 100 000 cells in 
CytoconTMBuffer II) on the gel mixture, incubated for 10 minutes at 37°C for attachment and 
then covered with NGc medium. Two days after plating, migration was quantified by 
measuring the distance the cells had migrated away from the site where they were plated.   
 
3.8.  Transplantation 
In order to prepare cells for transplantation, they were trypsinized and re-suspended at the 
desired cell concentration in CytoconTMBuffer II containing 0.1% DNase. Cell suspension was 
kept on ice until transplantation was performed. Following transplantation remaining cells 
were replated onto PO/LN coated culture dishes for monitoring cell viability. 
 
3.8.1. Transplantation onto rat hippocampal slice cultures 
Using a vibroslicer, 400 µm horizontal sections were generated from the hippocampus of 9 – 
10 day-old Wistar rats. The slices included the dentate gyrus and the entorhinal and temporal 
cortex (Scheffler et al., 2003; Opitz et al., 2007). They were transferred onto a polyester 
membrane and cultivated at 35°C, 5% CO2 and saturated air humidity in an initial culture 
medium containing 25% normal horse serum, which was gradually replaced after 3 – 5 days 
by chemically defined, serum-free culture medium based on DMEM/F12, N2 supplement and 
B27 supplement. Medium was changed every other day and 5 – 7 days after explantation a 
cell suspension of 50 000 cells in a 1 µl volume was spotted onto the entorhinal cortex of the 
slice using an injection device.  
 
3.8.2. Transplantation into the rodent brain 
Cell transplantation into the brain of 12 week-old rats (SD) was performed as described 
previously (Crawley et al., 2003). Briefly, SD rats were anesthetized (10 mg/kg Xylacin, 80 
mg/kg Ketamine) and clamped in a stereotactic frame. A midline incision was performed and 
the injection position was determined (coordinates for transplants into the left striatum: 
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anteroposterior + 0.2mm; mediolateral –2.9mm; ventral 4.8mm, coordinates for transplants 
into the SVZ close to the rostral migratory stream: anteroposterior + 1.6mm; mediolateral      
–1.25mm; ventral 5.6mm). A hole was drilled at the target site and 1 µl of cell suspension 
containing 100 000 cells/µl were carefully injected over a 5 min period into either the left 
striatum or into the SVZ. Engrafted animals received daily injections of cyclosporine (10 
mg/kg). Eight days after transplantation, the recipients were anesthetized with pentobarbital 
and perfused with 4% paraformaldehyde. The brains were removed and cryoprotected in 
15% sucrose in PBS over night, followed by 30% sucrose in PBS for 2 days. 
Immunofluorescence analysis (see 3.9.2) was performed to identify engrafted human cells in 
35 μm cryostat sections. All procedures were performed in accordance with institutional 
guidelines. 
Quantification of the total number of EGFP positive cells within the corpus callosum was 
performed on every second out of twenty consecutive 35 µm coronal brain sections 
encompassing the entire transplantation area. Three animals per condition were analysed. 
Data were presented as mean number and standard derivation of counted EGFP positive 
cells per animal for each condition. 
 
3.8.3. Transplantation into the neonatal rodent brain 
Two-day-old (P2) Sprague-Dawley rats were shortly anaesthetised by hypothermia on ice for 
4 minutes. Hypothermia was chosen to anaesthetise P2 rats, as anaesthetics like ketamine 
cannot be applied to animals at this age without a pronounced increase in the mortality rate. 
The animals received 2 µl of purified and cryopreserved cell suspension (50 000 cells/µl) in 2 
deposits along the rostral/caudal axis of the right hemisphere by using a glass capillary. After 
transplantation, recipient rats were placed on a 37°C plate. Upon reaching their regular body 
temperature, they were placed back to the mother animal. Two weeks after transplantation, 
recipient rats were deeply anesthetized and perfused with 4% paraformaldehyde. The brains 
were removed and treated as described (see 3.9.2). 
 
3.9.  Immunocytochemistry and immunohistochemistry 
3.9.1. Immunocytochemistry 
Immunocytochemical analyses of the cells were performed using primary antibodies and 
appropriate secondary antibodies labelled with Cy3, Cy5 or FITC. Nuclei were visualised by 
DAPI staining (1:10000 in PBS, 4 minutes incubation). Cells were fixed in 4% 
paraformaldehyde for 10 minutes. For the staining of intracellular markers cells were 
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permeabilized with 0.1% Triton X-100 in PBS for 20 minutes. Blocking was performed with 
10% FCS, in PBS for 1 hour. Samples were incubated with primary antibodies diluted in 
blocking solution at room temperature for 3 to 4 hours, washed twice in PBS and incubated 
with secondary antibody diluted in blocking solution for 45 minutes. The cells were washed in 
PBS, counterstained with DAPI and mounted with vectashield mounting solution.  
For BrdU staining 0.5% Triton X-100 in PBS was used for permeabilizing the cells. After 
washing cells were incubated with 2 M HCL for 10 minutes, washed in PBS, equilibrated 
using 0.1 M borate buffer, washed again in PBS, followed by an incubation with the primary 
antibody diluted in blocking solution at room temperature over night. Staining with the 
secondary antibody was performed as described.  
 
3.9.2. Immunohistochemistry 
Fixed and cryoprotected brain tissue of transplanted animals (see 3.8.2) was sectioned with 
a cryostat in 35 to 40 µm thick brain slices. Sections were permeabilized/blocked with 10% 
FCS for 1 hour. 0.1% Triton X-100 was added to the blocking solutions for stainings of 
intracellular markers. Incubation with primary antibody was for 16 hours followed by washing 
steps with PBS for at least 2 hours. Incubation with secondary antibodies was for 2 hours. All 
staining steps were performed at room temperature.   
For immunohistochemical analysis of slice cultures, cultures were fixed in 4% 
paraformaldehyde for 4 hours and subsequently washed several times with PBS. Slices were 
permeabilized/blocked with 0.1% Triton X-100 + 10% FCS for 6 hours at 25°C. Incubation 
with primary antibody was for 16 hours at room temperature, followed by washing steps with 
PBS for 5 hours. Incubation with the secondary antibodies was for 2 hours at room 
temperature.  
All antibodies, sources and dilutions are listed in the Material section (2.6.1 and 2.6.2).  
 
3.10. RT-PCR 
For reverse transcriptase polymerase chain reaction (RT-PCR) triplicate total messenger 
RNA (mRNA) samples were isolated using an mRNA extraction kit (see 2.7.2), following the 
supplierʼs instructions. 0.5 to 1 µg total mRNA were used for reverse transcription with the 
iScript cDNA synthesis kit (see 2.7.2) following the manufacturerʼs protocol. PCR reactions 
were run in at least triplicates using Taq Polymerase. In order to compare the expression 
levels of different genes, all data were normalized to GAPDH by performing 15, 20 and 25 
cycles. PCR conditions and cycle numbers were then adjusted to each primer pair for 
specific DNA amplification on commercially available human fetal brain tissue (single donor, 
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female, 19 weeks of gestation). The selected number of cycles varied from 28 to 35 cycles 
depending on the particular cDNA abundance with denaturation at 94°C for 1 minute, 
annealing temperatures of 58°C to 63°C for 1 minute according to the primers, and 
elongation at 72°C for 2 minutes. Omission of transcriptase during RT or cDNA sample 
during PCR served as negative controls. All reactions were performed on a T3 Thermocycler. 
Primers used are listed in the Material section (2.7.1).  
The components of the PCR reaction were as follows: 
Master Mix (MM): 
MM Stock Final Concentration Volume in µl (total 10 ml) 
PCR Buffer 10 x 2 x 2000 
MgCl2 50 mM 6 mM 600 
dNTPs 100 mM 0.4 mM 40 (160) 
dH2O   7240 
 
Primer Mix: Primer concentration 100 µM = 100 pmol/µl 
Primer-Mix Volume in µl 
Primer forward 20 µl 
Primer reverse 20 µl 
dH2O 360 µl 
 
PCR-reaction: 
12.5 µl Master Mix 
8.3 µl dH2O 
3 µl Primer-Mix 
1 µl  cDNA (100 ng/µl) 
0.2 µl Taq 
25 µl 
 
After the PCR-reaction was performed, 4 µl of the 6 x loading buffer was added to each tube. 
The samples were electrophoretically separated on an agarose gel (1.5% agarose in TAE-
buffer + 1 µl ethidiumbromide/ 10 ml buffer) at 100 V for approximately 20 minutes. The 
agarose gel was exposed to UV-light in a gel documentation system to visualize DNA bands. 
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3.11. Electrophysiological recordings of purified neurons∗ 
Cells grown on 13 mm diameter plastic coverslips (Nunc) or on hippocampal rat slice cultures 
were transferred to a chamber that was mounted to a x-y stage and continuously superfused 
with aCSF at 1–2 ml/min. This aCSF contained the following (in mM): 140 NaCl, 3 KCl, 2 
CaCl2, 1 MgCl2, 25 D-glucose, and 10 Hepes/NaOH (pH 7.35, 305-315 mosmol/kg). 
Recordings were performed at room temperature. Cells were visualized using an upright 
microscope equipped with near-infrared differential interference contrast (IR-DIC) and 40 x 
water immersion objective (Zeiss). In slice cultures transplanted cells were identified by their 
EGFP fluorescence (Opitz et al., 2007). Whole cell current-clamp and voltage-clamp 
recording was carried out with an Axopatch-200B amplifier (Axon Instruments, Foster City, 
CA) that was interfaced by an A/D-converter (Digidata 1320, Axon) to a PC running PClamp 
software (vers. 9, Axon). For recordings of membrane potential or current, the patch pipette 
(tip resistance 3–5 MΩ) contained the following (in mM): 120 potassium gluconate 
(C6H11O7K), 20 KCl, 10 NaCl, 10 EGTA, 1 CaCl2, 4 Mg ATP, and 0.4 Na GTP, 10 
HEPES/KOH (pH 7.2, 280-290 mosmol/kg). Command potential in voltage-clamp recordings 
was corrected for a 13 mV junction potential. For some recordings of postsynaptic currents, 
another pipette filling solution was used (in mM): 110 cesium methanesulfonate 
(CH3O3SCs), 10 CsCl, 10 TEA-Cl, 5 QX-314 Cl, 10 EGTA, 1 CaCl2, 4 Mg ATP, and 0.4 Na 
GTP (pH 7.2, 280-290 mosmol/kg). For the latter solution holding potential was corrected for 
a 9 mV junction potential. Signals were filtered at 2 kHz and recorded at a rate of 10 kHz.  
 
                                                 
∗ All functional studies were performed by T. Opitz 
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4. RESULTS 
4.1. Generation and validation of a lineage selection protocol to derive pure   
cultures of immature neurons from hES cells  
4.1.1. Expression profile of doublecortin at different stages of neural differentiation in  
lt-hESNSC 
A key prerequisite for the application of hES cells in neural repair is the generation of defined 
neural cell types at high purity. Neuronal replacement might benefit from the availability of 
purified populations of immature neurons capable of integrating into host tissue. An attractive 
candidate marker for immature neurons is Doublecortin (DCX), a 40 kDa protein that 
associates with and stabilizes microtubules (Francis et al., 1999; Gleeson et al., 1999; Taylor 
et al., 2000). In vivo, the expression of DCX is restricted to newborn and migrating neurons 
during CNS development and zones of adult neurogenesis (Chelly, 1998; Gleeson et al., 
1998; LoTurco, 2004; Rao & Shetty, 2004; Couillard-Despres et al., 2005; Bernreuther et al., 
2006). The expression is initiated with neuronal determination and is described to be down-
regulated during neuronal maturation (Kempermann et al., 2004; Couillard-Despres et al., 
2005). To investigate whether in vitro generated neural precursors derived from hES cells 
reflect a DCX expression pattern comparable to the in vivo situation, a recently described 
population of long-term self-renewing hES cell-derived neural stem cells (lt-hESNSC; see 
1.1.3) was investigated for the expression of DCX under proliferating and differentiating 
conditions by immunocytochemistry. This cell population was derived by mechanical isolation 
of neural rosettes from plated embryoid bodies and subsequent proliferation in the presence 
of FGF2 and EGF (Koch et al., 2006). The method yields a homogeneous monolayer of 
neuroepithelial stem cells, expressing nestin but not DCX. Under proliferating conditions, 
expression of DCX was restricted to very occasional spontaneously differentiating neurons  
(< 1%, Figure 4.1 a). When differentiation was induced by growth factor withdrawal, DCX 
expression increased alongside the appearance of the neuronal marker beta III-tubulin 
(Figure 4.1 b). At this stage, DCX expression was restricted to cells with polar neuronal 
morphology. Upon further differentiation DCX expression could also be observed in more 
mature neurons expressing MAP2ab (Figure 4.1 c). DCX was barely detectable in neurons 
expressing the mature neuronal marker NeuN (Figure 4.1 d), suggesting that, in agreement 
with what is observed during normal development in vivo, DCX is down-regulated in 
terminally differentiated neurons. Thus, DCX is specifically expressed in young immature 
neurons during differentiation of lt-hESNSC. Expression of the astrocytic protein GFAP or the 
oligodendroglial antigen O4 could not be detected in DCX expressing cells. Ki67 
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immunostaining and BrdU labelling showed no evidence of cell proliferation within the DCX-
positive population (Figure 4.1 f-g). Taken together, DCX-expression in this system 
delineates an early stage of postmitotic neuronal differentiation.  
 
Figure 4.1: Expression profile of DCX in lt-hESNSC during in vitro differentiation. (a) Cultures of 
proliferating lt-hESNSC exhibited only very occasional DCX-positive neurons. The expression of DCX 
and nestin was mutually exclusive. (b) Two days after induction of differentiation, DCX was co-
expressed in emerging beta-III tubulin-positive neurons. (c) At later stages of neuronal differentiation, 
DCX-positive neurons co-expressed MAP2ab (12 days of differentiation). (d) DCX was hardly 
detectable in NeuN-positive cells, suggesting down-regulation upon terminal differentiation. (e) 
Quantification of marker expression during the first 8 days of in vitro differentiation of lt-hESNSC. (f) 
Ki67 staining and (g) BrdU labelling revealed no evidence of cell proliferation in DCX-positive neurons. 
Scale bars: a-c,g 50 µm d,f 25 µm. 
 
4.1.2. Lt-hESNSC stably expressing a doublecortin reporter/selection marker  
Based on the highly selective expression of DCX in neurons, lt-hESNSC were transfected 
with a construct carrying the EGFP gene under the control of the human DCX promoter 
alongside with a constitutively expressed neomycin resistance gene. Transfected cells were 
replated and subsequently selected in the presence of 50 µg/ml G418 for 3 weeks. Clones 
were picked and further expanded. Faithful co-expression of the DCX protein and the EGFP 
reporter was investigated on separately plated cells of each clone following 8 days of 
differentiation. Four out of 27 clones analysed showed strong and exclusive expression of the 
EGFP transgene in DCX immunoreactive neurons. The remaining clones showed either 
background expression in non-neuronal cells (n=5) or an EGFP expression level insufficient 
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for cell sorting (n=18). A detailed in vitro differentiation study of the four clones without 
background expression revealed that the EGFP expression in the proliferating stage was 
restricted to sporadic spontaneously differentiating cells with immature neuronal morphology 
(Figure 4.2 a). When stained for DCX, differentiating cells showed co-expression of DCX and 
EGFP (Figure 4.2 b). Co-expression of the neural precursor marker nestin and of EGFP was 
largely exclusive (Figure 4.2 c). EGFP-labelled cells were consistently positive for beta-III 
tubulin (Figure 4.2 d). With further maturation, EGFP-positive cells also co-expressed 
MAP2ab (Figure 4.2 e). Co-expression of EGFP with DCX during the different stages of 
differentiation indicates that the expression of EGFP in the selected clones reflects the 
endogenous expression profile of the DCX protein in lt-hESNSC (see 4.1.1). Consolidated 
clones of DCX-EGFP-transduced cells could be further propagated without losing their 
neurogenic potential. For example, cells expanded in FGF2 and EGF for 4 and 11 passages 
and subsequently differentiated for 7 days yielded 26±2.2% and 25±2.5% EGFP-positive, 
DCX-immunolabeled neurons, respectively. Expanded clones could be frozen and stored in 
liquid nitrogen without loss of their proliferative and neurogenic potential.  
              
Figure 4.2: Expression of the DCX-EGFP transgene in differentiating lt-hESNSC. (a) EGFP-
positive cells alongside still undifferentiated precursors. (b) Co-expression of EGFP and DCX protein 
confirmed faithful recapitulation of DCX expression by the reporter construct. (c-e) DCX-EGFP-positive 
cells were negative for nestin (c) but co-expressed the neuronal markers beta-III tubulin (d) and 
MAP2ab (e). Cells were captured during (a) proliferation and at (c) 2, (b,d) 8 and (e) 12 days of in vitro 
differentiation. Scale bars: a-b 100 µm, c-e 50 µm. 
 
4.1.3. Purification of DCX-EGFP-positive neurons by FACS 
A key challenge in stem cell technology is the generation of purified sub-lineages. Because 
the in vitro data revealed a highly neuron-specific EGFP-fluorescence within the selected 
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clones, a question to address was whether these cells can be exploited for the generation of 
pure neuronal cultures by fluorescence activated cell sorting (FACS). A major issue in 
neuronal lineage selection is the identification of a time point where the desired neurons are 
present in sufficient numbers but still immature enough to tolerate sorting, replating or 
cryopreservation. Quantitative analysis of DCX-EGFP-positive cells showed a continuous 
increase in the numbers of EGFP-positive cells within the first 3 weeks of differentiation (from 
28±2.8% by day 7 up to 55±6% by day 21). Within the first week of differentiation, the DCX-
EGFP-positive cells still displayed an immature morphology with most of them exhibiting only 
a few unbranched processes. Less than 50% of the EGFP-positive cells expressed the more 
mature neuronal marker MAP2ab, indicating a still immature stage of differentiation. Based 
on these observations, day 8±1 was chosen as an ideal time window for sorting. Within this 
time period, an average of 31±2,8% of the cells expressed the DCX-EGFP transgene.  
Preparative FACS was performed with EGFP fluorescence intensity as the only sorting 
criterion. The population of EGFP-positive neurons was readily distinguishable from other cell 
types (undifferentiated or glial cells) by virtue of their EGFP-fluorescence (Figure 4.3 a). Re-
analysis of the sorted population showed efficient enrichment of the EGFP-positive cells 
(Figure 4.3 b). Following replating, most of the cells survived, exhibited strong EGFP 
fluorescence (Figure 4.3 c), and were negative for nestin (Figure 4.3 d). Twenty-four hours 
after plating up to 95% (92.3±2.5%) of the cells were found to co-express beta-III tubulin and 
EGFP (Figure 4.3 e). The replated cells initiated neurite outgrowth within the first 24 hours 
after attachment (Figures 4.3 c-f). Four days after FACSorting the cells exhibited distinct 
neuronal phenotypes with extension of long neurites forming a network-like architecture 
(Figure 4.3 g).  
Plated neurons survived up to 3 weeks in standard media (containing B27 supplement, but 
no neurotrophic factors). Supplementation of the media with BDNF and GDNF promoted the 
development of complex neuronal networks, and enhanced the survival of neurons (Figure 
4.3 h). Neurotrophic factors are also produced from astrocytes. Therefore, another method to 
supplement standard media (containing B27 supplement, but no extra added neurotrophic 
factors) is to use astrocytic conditioned media or to directly co-culture the neurons on 
astrocytes (see 3.5). Quantification performed 3 weeks after plating and propagation in 
astrocyte-conditioned medium revealed that 40±4% of the neurons had survived. These 
neurons could be further maintained for a total period of more than 2 months without overt 
cell loss.  
After further differentiation the majority of the neurons acquired a GABAergic phenotype. 
Immunohistochemical analysis performed 3 weeks after FACSorting and replating in 
astrocyte-conditioned medium revealed that 61±5.4% of the purified neurons expressed 
   Results 
50 
GABA. These cells displayed a bipolar to multipolar morphology and were partially positive 
for GAD67 (Figure 4.3 i-j). Other neuronal subtypes, such as tyrosine hydroxylase (TH) 
positive neurons were detected only very occasionally (< 0.1%, Figure 4.3 k). Differentiation 
towards a GABAergic neuronal phenotype was independent of the passage number of the 
DCX-EGFP lt-hESNSC reporter cell line. 
                 
Figure 4.3: FACS-based lineage selection of DCX-EGFP-positive human neurons. (a) After 7-9 
days of in vitro differentiation, a dominant fraction of fluorescent cells was detected in the DCX-EGFP 
cultures by FACS. (b) Re-analysis revealed enrichment of EGFP-positive cells up to 95%. (c-d) 
Twenty-four hours after FACS and replating, sorted cells (c) maintained strong EGFP fluorescence, 
(d) were largely negative for nestin and (e) positive for beta-III tubulin. (f-h) Neurite outgrowth 24 hours 
(f), 4 days (g) and 1 month (h) after replating. (h) Cells were propagated as shared media cultures 
with primary mouse astrocytes to promote long-term survival. (i-j) Expression of GABA (i) and GAD67 
(j) three weeks after FACSorting and differentiation in astrocyte-conditioned medium. (k) Occasional 
neurons were found to express TH. Note: down-regulation of EGFP in this neuron might be due to 
advanced differentiation. Scale bars: c,e-h 50 µm, d and i 100 µm, j-k 10 µm. 
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The expression profile of DCX in lt-hESNSC revealed that DCX is down-regulated in more 
differentiated neurons. To enable cell detection by fluorescent label beyond down-regulation 
of the DCX-EGFP transgene a lt-hESNSC clone labelled with EGFP under a ubiquitous 
promoter (Figure 4.4 a; provided by Philipp Koch) was transfected with a construct carrying a 
DsRED2 gene as fluorescence detection marker under the control of the human DCX 
promoter. Comparable to the DCX-EGFP transfected and selected lt-hESNSC the 
transfected cells were selected in the presence of 50 µg/ml G418 for 3 weeks. Clones were 
picked and further expanded as described for the DCX-EGFP transfected cells. In vitro 
differentiation of the selected clones showed comparable results to the ones obtained for the 
DCX-EGFP construct with DsRED2 expression only detectable in cells with neuronal 
morphology (Figure 4.4 b). The population of DsRED2- and EGFP-positive cells was 
distinguishable by FACS resulting in two fluorescent peaks, from the cells that were 
expressing only EGFP (Figure 4.4 c). DCX-DsRED2 sorted cells could be replated and 
further cultured (Figure 4.4 d-e). This labelling system should allow the identification of DCX-
DsRED2:PGK-EGFP purified cells by virtue of their EGFP-fluorescence in more differentiated 
stages where DCX is down-regulated.  
 
                       
 
Figure 4.4: FACS-based lineage selection of DCX-DsRED2:PGK-EGFP-positive human 
neurons. After 7-9 days of in vitro differentiation, lt-hESNSC (a) ubiquitously expressing EGFP (b) co-
expressed DsRED2 in cells showing neuronal morphology. (c) The DsRED2-positive cells could be 
detected by FACS. Twenty-four hours after FACS and replating, sorted cells maintained strong (d) 
DsRED2 and (e) EGFP fluorescence. Scale bars: a-b 200 µm, d 50µm and e 100 µm. 
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4.1.4. Functional maturation of purified hES cell-derived neurons  
To assay functionality of the selected cells, whole-cell patch-clamp recordings were 
performed on DCX-sorted neurons∗. To facilitate long-term survival and functional maturation, 
the DCX-EGFP sorted neurons were co-cultured for 4 weeks with primary mouse astrocytes. 
Neurons gained fast transient inward currents sensitive to the selective Na+ channel blocker 
tetrodotoxin (TTx, 300 nM) and complex outward currents. The latter could be shown to 
consist of at least two components: a fast activating and inactivating one, sensitive to 3 mM 
4-aminopyridine (4-AP) and resembling characteristics of A-type K+ current; and a slowly 
activating sustained component reminiscent of delayed rectifier type (n=3, Figure 4.5 a-d). All 
neurons tested (n=13) fired repetitive action potentials upon sustained depolarization (Figure 
4.5 e). Furthermore, following application (500 ms) of either the AMPA/KA receptor agonist 
kainic acid or GABA receptor agonist muscimol, the neurons displayed surface expression of 
AMPA/kainate and GABAA receptors (n=3, Figure 4.5 f) as a prerequisite for the formation of 
glutamatergic and GABAergic synapses.  
 
 
Figure 4.5: Electrophysiological properties of DCX-EGFP purified neurons differentiated 4 
weeks in vitro. Voltage-dependent whole cell current (a) consisted of a fast transient inward 
component, which could be blocked by 300 nM TTx and (b) a complex outward current. (c) The latter 
consisted of a 4-AP insensitive, slow activating, and during the test pulse (90 ms) non-inactivating 
component. (d) Digital subtraction of the traces shown in b and c revealed a 4-AP-sensitive fast 
activating and inactivating current. (e) Neurons displaying the current pattern shown in a, were able to 
fire multiple action potentials upon long-lasting (1 s) depolarizing current injection. (f) Brief (500 ms) 
application of either the AMPA/KA receptor agonist kainic acid or GABAA receptor agonist muscimol 
elicited a clear current response.  
                                                 
∗ All functional studies were performed by T. Opitz 
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To further explore the ability of the selected neurons to engage in synaptic circuits, purified 
neurons were transplanted onto hippocampal slice cultures prepared from P10 rats, a 
paradigm known to promote long-term survival and functional maturation of ES cell-derived 
neurons (Benninger et al., 2003). As EGFP down-regulation indicates a more mature 
neuronal stage, functional integration was evaluated by patch-clamp recordings 4 weeks 
after transplantation, selectively on those neurons with lower EGFP expression (Figure 4.6 a-
c). The cells exhibited both transient and persistent outward, and large amplitude transient 
inward currents. All of the neurons recorded (n=9) were able to fire repetitive action potentials 
upon long-lasting depolarization. In addition, spontaneous postsynaptic currents (PSCs) 
could be recorded in 8 out of 9 neurons. In some recordings (n=3) a Cs+-based pipette 
solution for a closer characterization of those PSCs was used. Recordings at different holding 
potentials revealed a reversal potential of postsynaptic currents between -20 and -60 mV 
(Figure 4.6 a). Large PSCs in cells located in the CA1 region could be evoked by electrical 
stimulation with a stimtrode placed in the stratum radiatum (Figure 4.6 b). Those evoked 
PSCs reversed polarity at -48 mV (Figure 4.6 c), close to the calculated ECl of -43 mV, 
suggesting synaptic input via GABAA receptors. Taken together, the data indicate that the 
population of human cells selected with the DCX-EGFP transgene may acquire functional 
properties of mature neurons upon in vitro differentiation. 
     
Figure 4.6: Postsynaptic currents in DCX-EGFP-selected neurons propagated on hippocampal 
rat slice cultures. (a) Four weeks after deposition, PSCs could be observed which reversed between 
-60 and -20 mV. (b) Electrical stimulation of presynaptic fibers evoked monosynaptic PSCs. (c) 
Plotting PSC amplitude over holding potential revealed a reversal potential of -48 mV.  
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4.2. Generation of an efficient cryopreservation protocol for human neurons 
4.2.1. Cryopreservation of purified hES cell-derived neurons 
An essential prerequisite for the effective use of hES cell-derived neurons for further 
biological and pharmacological applications is the development of efficient cryopreservation 
protocols. When applying conventional slow-cooling and thawing protocols (e.g. a -1°C/min 
cooling rate and 37°C thawing temperature) involving commercial serum-free freezing 
formulations or standard protocols composed of 90% FCS and 10% dimethyl sulfoxide 
(DMSO), sorted DCX-EGFP-positive cells exhibited relatively low survival rates between 30% 
and 35% directly after thawing analysed by trypan blue exclusion assays. Therefore different 
freezing solutions were formulated including one containing DMSO, the cryoprotectant myo-
inositol, polyvinyl-alcohol as ice-controlling agent, and serum replacement (KO-SR) with an 
osmolarity of 300-400 mOsm/kg (see Materials & Methods). Using the latter, the post-
thawing survival could be enhanced up to 47% (40±5%) (Figure 4.7 d).  
To further increase post-thaw survival, cells were pre-treated with the general caspase 
inhibitor z-VAD-fmk 30 minutes before freezing. Apoptosis mediated by a caspase-
dependent mechanism was shown to significantly contribute to cryopreservation-associated 
cell loss. Furthermore, caspase inhibition has been successfully employed to improve cell 
survival upon freezing of undifferentiated hES cells and other cell types (Stroh et al., 2002; 
Heng et al., 2006). Pre-incubation of DCX-EGFP-sorted neurons with 500 nM z-VAD-fmk for 
30 minutes significantly reduced the number of cells undergoing cell death, resulting in an 
increased survival rate up to 83% (70.1%±13.1%), as detected by trypan blue exclusion 
assays directly after thawing (Figure 4.7 d). Furthermore, it was tested whether z-VAD-fmk 
treatment prior to cryopreservation also protects the neurons within the first 20 hours after 
thawing and replating. To quantify caspase-mediated apoptosis 20 hours after thawing and 
replating, a luminescent caspase-assay was performed which measures the caspase-3 and -
7 activities. Both caspase-3 and caspase-7 play key roles in mediating apoptosis of 
mammalian cells (Thornberry et al., 1997; Le et al., 2002). A reduction by 3.5 fold in 
caspase-3 and -7 activities could be measured in z-VAD-fmk-treated neurons compared to 
untreated control cells (Figure 4.7 e).  
To show that the effect of the general caspase inhibitor was only temporary, treated and 
untreated thawed neurons were further cultured for four days, and subsequently incubated 
with 250 nM staurosporine for 3 hours, followed by a luminescent caspase assay. At this time 
point no significant difference in the induction of caspase-3 and -7 activity was detected 
between z-VAD-fmk treated and non-treated cells.  
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Two days after thawing and plating, z-VAD-fmk-treated cells still showed strong expression 
of EGFP (Figure 4.7 a), a neuronal morphology with prominent neurites, and 
immunoreactivity to DCX and beta-III tubulin (Figure 4.7 b-c). Maintenance of functionality 
was further confirmed by patch-clamp analysis. This analysis showed that thawed neurons 
co-cultured for four weeks with mouse primary astrocytes were able to generate functional 
ion channels, to fire repetitive action potentials, and to display functional AMPA and GABA 
receptors. Taken together, these data indicate that cryopreservation does not impair the 
physiological properties of the cells (Figure 4.7 f-h).   
 
                    
 
Figure 4.7: Cryopreservation of purified hES cell-derived neurons. (a-c) Two days after thawing, 
sorted and z-VAD-fmk treated cells maintained (a) strong expression of the DCX-EGFP transgene, (b) 
the DCX protein and (c) the neuronal marker beta-III tubulin. (d) Quantification of the post-thaw cell 
survival of cryopreserved DCX-EGFP-sorted cells with and without pre-treatment with z-VAD-fmk (* P 
< 0,05). (e) Quantification of caspase-3 and -7 activity of cryopreserved DCX-EGFP sorted cells with 
and without z-VAD-fmk pre-treatment as detected 20 hours after cryopreservation and replating (* P < 
0.01). (d-e) Bars depict the mean fraction of cells in the different cell populations. (f) Thawed neurons 
displayed voltage-dependent whole cell current and (g) were able to fire multiple action potentials 
upon long-lasting (1 s) depolarizing current injection. (h) Application (500 ms) of either the AMPA/KA 
receptor agonist kainic acid or GABA receptor agonist muscimol, elicited a clear current response. 
Scale bars: c and e 50 µm, d 100 µm. 
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4.2.2. Transplantation of purified and cryopreserved neurons into the neonatal rodent 
brain 
To analyze whether cryopreservation impairs in vivo survival and integration capacity of hES 
cell-derived neurons, 100 000 freshly thawed neurons were injected unilaterally into the 
ventricles of the developing brain of P2 rats. Two weeks after transplantation, animals were 
sacrificed and their brains explanted for immunohistochemical analysis. DCX-EGFP-
expressing cells showed distribution in a variety of host brain regions, including the rostral 
migratory stream, the olfactory bulb and the hippocampus (n=7) (Figure 4.8 a-h). EGFP-
positive cells displayed a clear neuronal morphology with delineation of neurites (Figure 4.8 
b,g). All engrafted EGFP-positive donor cells co-expressed a human specific nuclear antigen 
(Figure 4.8 b,d,f-h). Transplanted neurons found in the rostral migratory stream displayed a 
bipolar morphology with an elongated leading process, oriented towards the olfactory bulb, 
which is suggestive of a migratory phenotype (Figure 4.8 b). In contrast, cells that reached 
the olfactory bulb displayed a multipolar morphology with extension of branched neurites 
(Figure 4.8 c-d). Some EGFP-positive neurons were located in the dentate gyrus (Figure 4.8 
f,h), as well as between the CA1 region and the dentate gyrus (Figure 4.8 g) of the 
hippocampus. These data indicate that FACS and cryopreservation do not affect survival and 
integration of hES cell-derived neurons in vivo.  
 
 
 
Figure 4.8: Purified and cryopreserved hES cell-derived neurons following in vivo engraftment 
into the P2 rat brain. (a) Schematic representation (red) of the distribution of DCX-EGFP-positive 
cells along the SVZ, the rostral migratory stream (RMS), the olfactory bulb (OB) and (e) in the 
hippocampus (HC). Co-expression of (b) EGFP and the human specific nuclei antigen (hNuc) in 
transplanted cells migrating along the rostral migratory stream, (c) within the olfactory bulb and (d-h) 
within the hippocampus. Scale bars: b-c,g 50 µm, d,f,h 100 µm.  
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4.3.  Enhanced migration of purified human neurons 
The expression of DCX in the developing and adult brain is associated with a strong 
migratory potential (Bai et al., 2003; Tanaka et al., 2004). During development, newborn 
DCX-positive neurons leave the VZ and migrate towards the apical surface of the developing 
cortex. In the adult brain DCX-positive neurons, born in the SVZ or the dentate gyrus, migrate 
towards the olfactory bulb and the outer layer of the dentate gyrus, respectively. To study 
whether the DCX-EGFP purified human neurons share an enhanced migration potential with 
their in vivo counterparts, different in vitro and in vivo migration assays were performed. To 
that end, DCX-EGFP purified human neurons (also termed hES-N), derived from 8±1 days 
pre-differentiated lt-hESNSC expressing the EGFP reporter gene under the control of the 
DCX promoter, were investigated. Migration of the purified neurons was compared with that 
of the 8±1 days pre-differentiated lt-hESNSC expressing the EGFP reporter gene under the 
control of the DCX promoter which were not purified, i.e. termed to as hES-NSC+N. This 
population consisted of 31±2.8% immature DCX-EGFP-positive neurons and 69±2.8% other 
cell types, most of which expressed nestin (Figure 4.1 e) and showed a precursor 
morphology. 
 
4.3.1. In vitro migration of purified human neurons 
In a first set of experiments, 100 000 hES-N as well as 100 000 hES-NSC+N were plated on 
a matrigel scaffold (see 3.7.2). This scaffold mimics the in vivo extracellular matrix and has 
been shown to promote migration in vitro (Durbec et al., 2008). Two days after plating the 
hES-N showed a distribution across a large area with strong migration of individual neurons 
from the plating site (Figure 4.9 c-d). In contrast, the hES-NSC+N control population formed 
spherical clusters and hardly any cell migrated away from these clusters. Instead, only limited 
axonal outgrowth could be observed (Figure 4.9 a-b). Interestingly, the large number of DCX-
EGFP-positive neurons within the hES-NSC+N control cells, which have the potential to 
migrate as a pure population, remained confined to the spherical clusters and did not migrate 
out on the matrigel scaffold. 
A similar result was observed when a Boyden chamber migration assay was performed using 
medium not containing additional chemoattractants (see 3.7.1). A significant higher number 
of EGFP-positive neurons from the hES-N were found to reach the lower side of the chamber 
compared to the EGFP-positive neurons within the hES-NSC+N control-population 20 hours 
after plating (Figure 4.9 e). Again, only limited migration of DCX-EGFP-positive neurons in 
the control population was observed. Thus, the purified DCX-EGFP-positive immature 
neurons show a strong migratory phenotype.  
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Figure 4.9: In vitro migration-assays of purified human neurons. (a-d) Matrigel migration assay. 
(a) Sphere-like structures of plated hES-NSC+N showing (b) axonal outgrowth but no single cell 
migration and (c) centrifugal distribution of plated hES-N (d) reflecting strong single cell migration. (e) 
Mini-chamber migration monitored after 20 hours in culture towards medium. Bars represent 
percentage of neurons counted on the lower side of the migration chamber (see 3.7.1) either from 
plated hES-NSC+N (black), or from hES-N (white). Cell numbers were normalised to the number of 
DCX-EGFP-positive plated cells (* P < 0.05). Scale bar: b-e 510 µm. 
 
4.3.2. Migration of purified human neurons on hippocampal rat slice cultures  
The above made observations raised an interesting question: Why do the purified human 
neurons alone have enhanced migration capacity whereas the same neurons within the hES-
NSC+N control cells do not show this property?  
To investigate whether the enhanced migration capacity of purified neurons is conserved in 
an environment closer to an in vivo system consisting of different cell types and migration 
cues, DCX-EGFP-positive neurons purified by FACS (hES-N) and control cells, which were 
not purified but contained DCX-EGFP-positive cells as well as less differentiated cells (hES-
NSC+N), were deposited on hippocampal slice cultures generated from day 9 to 10 postnatal 
rats (Benninger et al., 2003; Opitz et al., 2007). Migration capacity was assessed 7 (n=40) 
and 14 (n=14) days after spotting. In this experiment the enthorinal cortex was chosen as 
transplantation site, because from here projections of the perforant path approach the 
dentate gyrus serving as potential guiding structures for migrating cells (Benninger et al., 
2003). Within 7 days hES-N were observed all over the hippocampal slice culture including 
the perforant path. Among other properties transplanted hES-N showed adaptation to the 
morphological structures of the slice with orientation orthogonal to the cortical structure: the 
CA1 and CA3 region of the pyramidal cell layer, and the granule cell layer of the dentate 
gyrus (Figure 4.10 a). By 14 days post transplantation many neurons showed distribution 
along the neuronal layers, the CA1 and CA3 region of the slice, displaying extensive 
intercellular axonal connections (Figure 4.10 b). Because of the extensive migration of the 
hES-N the deposition site of the cells on the slice could hardly be detected 7 days post 
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transplantation. In contrast, hES-NSC+N formed dense cores at the transplantation site 
(Figure 4.10 d). 14 days post transplantation the neurons within the hES-NSC+N 
transplanted cells generated numerous axonal projections into the hippocampus over long 
distances, but hardly migrated out of the transplantation core (Figure 4.10 e). The axonal 
projections could, however, be frequently traced within several 100 µm away from the 
transplantation core (Figure 4.10 e). The significant difference in migration capacity observed 
in the horizontal xy-axis was also observed in the vertical z-axis. Seven days after 
transplantation the number of EGFP-positive neurons that reached a depth of 175 µm and 
350 µm in the vertical z-axis were quantified in z-stacks (Figure 4.10 c,f,i). Whereas an 
average of 1.25±0.9 of the neurons within hES-NSC+N and 13.44±7.7 of the hES-N reached 
a depth of 175 µm per mm2, none of the neurons within the hES-NSC+N group but 6.5±4.39 
of the hES-N migrated to a depth of 350 µm per mm2. Migrating cells expressed the neuronal 
marker DCX, as well as human specific nuclear antigen (Figure 4.10 g-h).  
 
Figure 4.10: Migration of hES-N versus hES-NSC+N on hippocampal slice cultures. Distribution 
of transplanted neurons within (a,b) hES-N and (d,e) hES-NSC+N on hippocampal slices cultured 
(a,d) 7 and (b,e) 14 days after transplantation. (d) The red arrow marks the dentate gyrus (DG) and 
the yellow arrow the CA1 region of the hippocampal slice.  3D reconstruction of migrating neurons 7 
days post transplantation (c) of hES-N and (f) of hES-NSC+N. (g) EGFP/DCX and (h) EGFP/hNuc co-
staining 7 days post transplantation on hippocampal slices. (i) Quantification of the total numbers of 
cells reaching migration depths of 175- and 350 µm in the z-axis per mm2. Data based on n=4 per 
condition. Bars depict the mean fraction of cells in the different cell populations (* P < 0.005). Scale 
bars: a-b and d-e 850 µm, g-h 50 µm.   
 *   
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Thus, DCX-EGFP sorted neurons showed enhanced migratory ability also in hippocampal 
slice cultures. Furthermore, the distribution of the transplanted hES-N over the hippocampal 
slice cultures indicates that transplanted neurons might use hippocampal structures as 
guiding cues as they distributed along the neuronal layers including the CA1 and CA3 region 
of the hippocampal slice, whereas neurons within transplanted hES-NSC+N did not show 
these characteristics. 
 
4.3.3. In vivo migration of purified human neurons in the CNS of adult rats 
On the basis of the above-presented data of the strongly enhanced migration of hES-N in 
vitro and on hippocampal slice cultures, a central question was whether this migratory ability 
is maintained in an in vivo environment. To address this question, 100 000 FACS-purified 
DCX-EGFP-positive neurons (hES-N) or control cells which were not purified but contained 
DCX-EGFP-positive cells as well as less differentiated cells (hES-NSC+N) were transplanted 
into the striatum (n=16) or the SVZ close to the rostral migratory stream (n=15) of adult rats. 
Eight days post transplantation the animals were sacrificed and the brains were analyzed 
(Figure 4.11). In the animals that received hES-NSC+N either transplantaed into the striatum 
or the SVZ, the grafts formed densely packed clusters with very few cells migrating out of the 
transplantation site (Figure 4.11 b). In the animals that received the hES-N, however, the 
grafts consisted of only small transplantation cores and large numbers of migrating cells in 
the surrounding brain parenchyma (Figure 4.11 c-d,f). The hES-N were primarily oriented 
towards and along preexisting fiber tracks such as the corpus callosum (Figure 4.11 a,c-d). 
The hES-N transplanted in the SVZ also appeared to follow pre-existing migration tracts of 
the rostral migratory stream (Figure 4.11 f). Migrating cells displayed bipolar morphology with 
a leading process towards their direction of movement and relatively small somata, indicating 
active migration (Figure 4.11 d,f).  
Quantification of the total number of EGFP positive cells in the corpus callosum (see 3.8.2) 
amounted to an average of 534±108.70 cells per animal which received hES-N whereas no 
EGFP positive cells were found in the corpus callosum in the animals which received the 
hES-NSC+N. These data demonstrate that the strong migration capacity of the hES-N is 
maintained in vivo. The distribution of the cells further suggested that hES-N might be 
sensitive to pre-existing migration cues. As already observed in other paradigms, the hES-
NSC+N showed a strong tendency to form clusters with the DCX-EGFP-positive cells 
remaining insight these clusters. One possibility to explain these phenomenon is that the 
DCX-EGFP-positive neurons are attracted by factors secreted from the surrounding 
undifferentiated progenitor population which is present in the hES-NSC+N cell population and 
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that this “self attraction” of the transplantation core might be the reason for the only limited 
migration of DCX-EGFP-positive neurons away from the core in the control cell population. 
 
 
Figure 4.11: Migration of DCX-EGFP-positive cells in vivo. (a) Schematic representation of a 
coronal section through the brain of a transplanted animal illustrating the transplantation site (red) and 
the distribution of hES-N (green) 8 days post grafting. (b) Core formation of transplanted hES-NSC+N. 
Note that these grafts consist of EGFP-positive neuronal cells and nestin positive precursors. (c) HES-
N showed a strong tendency to migrate away from the transplantation site towards the corpus 
callosum and (d) appeared to follow preexisting fiber tracks of the corpus callosum. (e) Quantification 
of EGFP-positive neurons found in the corpus callosum within transplants of hES-NSC+N (black) and 
hES-N (white). Bars depict the mean fraction of cells in the different cell populations (* P < 0.007). (f) 
EGFP-positive neurons transplanted at the SVZ migrate along the rostral migratory stream co-
expressing the human Nuclei antigen (red). Scale bars: b-c 200 µm, d 100 µm, f 50 µm. 
 
 
 
  *   
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4.4.  Interaction between neural stem/progenitor cells and immature neurons 
A central issue in neural replacement therapy is the question of how grafted cells can be 
directed to particular targets within the CNS. Currently this question is far from being solved. 
Knowledge of signals controlling grafted neuronal progenitor migration might be of major 
importance for future transplantation approaches. Assessing neuronal migration within a pure 
neuronal culture, as well as within a cell mixture of neurons and less differentiated neural 
stem/progenitor cells, may help to understand some of the graft-intrinsic mechanisms (i.e., 
cell-cell interactions, attraction of neurons by the graft itself) that underlie NSC graft formation 
and restricted neuronal migration following NSC transplantation. 
4.4.1. Chemoattraction between neural stem/progenitor cells and immature neurons 
The previous in vitro and in vivo migration studies showed that DCX-positive neurons derived 
from human ES cells have an enhanced migration potential as a “purified population” (hES-
N), whereas only restricted migration occurs in a “non-purified” cell population (hES-NSC+N) 
consisting of neurons and less differentiated neural stem/progenitor cells. This might be due 
to an interaction existing between neurons and the yet undifferentiated neural 
stem/progenitor cells. In principle this interaction could be based on a direct cell-cell contact 
or mediated by soluble factors. To test whether soluble factors secreted from the neural 
stem/progenitor cell population may attract immature neurons, a mini-chamber migration 
assay was performed as described in 4.3.1. In this specific case though, proliferating NSCs 
were plated in the bottom well of the migration chamber, and either DCX-EGFP-positive 
neurons purified by FACS (hES-N) or control cells which were not purified, but contained 
DCX-EGFP-positive cells as well as less differentiated neural cells (hES-NSC+N) were plated 
in the upper well. In this setting 70% of the DCX-EGFP-positive neurons within the hES-
NSC+N population, and 92% of the DCX-EGFP-positive hES-N migrated towards the stem 
cell population within 20 hours (Figure 4.12). Compared to the previously performed mini-
chamber migration assay (see 4.3.1), in which 60% of the hES-N and 28% of the hES-
NSC+N migrated towards the medium in the lower well, the number of migrating neurons 
increased by 32% and 42%, respectively. Thus, proliferating NSCs appear to express at least 
one soluble factor, which has a strong chemoattractive effect on immature neurons.  
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Figure 4.12: Migration of neurons towards NSCs monitored after 20 hours in culture. Bars 
represent percentage of migrated neurons either from plated hES-N (white) or hES-NSC+N (black). 
Cell numbers were normalised to the number of DCX-EGFP-positive plated cells (* P < 0.05). 
 
4.4.2. Migration of immature neurons in a cell mixture with neural stem/progenitor 
cells on hippocampal rat slice cultures and in the CNS of adult rats 
Taking in account that DCX-EGFP-positive neurons are highly migratory once purified from 
the surrounding undifferentiated- or less differentiated neural stem/progenitor cells (see 4.3), 
and that factors secreted by the neural stem/progenitor cells may be responsible for an 
inhibitory effect on the migration of these neurons, we assessed whether increasing or 
reducing the ratio of neural stem/progenitor cells within a neural/neuronal population 
correlates with the restriction or enhancement in migration of the DCX-EGFP expressing 
neurons, respectively. To address this issue the migration of the purified neurons (hES-N) 
and the non-purified cells (hES-NSC+N) (see 4.3.2), which consist of about 30% immature 
DCX-EGFP-positive neurons and about 70% neural stem/progenitor cells (see 4.3), termed 
hES-NSC70+N30 should be compared to a third population consisting of 30% neural 
stem/progenitor cells and 70% immature DCX-EGFP-positive neurons. To generate such a 
population 70% of the hES-N was artificially mixed together with 30% of proliferating nestin 
positive NSCs, further named: hES-NSC30+N70. HES-NSC30+N70 were deposited on the 
enthorinal cortex of hippocampal slices, as performed in 4.3.2 (n=4). After 7 days in culture, 
the hES-NSC30+N70 showed migration of the EGFP-positive neurons towards various 
regions of the slice including the pyramidal cell layer (Figure 4.13 b,e). The migration of hES-
NSC30+N70 on the hippocampla slice was compared to the migration of hES-N and hES-
NSC70+N30. This comparison revealed that hES-N showed the strongest single cell 
migration of EGFP-positive neurons away from the transplantation site (Figure 4.13 e-f). 
Whereas some migration was observed in the case of hES-NSC30+N70 (Figure 4.13 c-d), 
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hardly any single cell migration could be detected in the group of the hES-NSC70+N30 
(Figure 4.13 a-b).  
To quantify the difference in the migration rate for the three populations, EGFP-positive 
neurons were counted that had migrated within the hippocampal slice reaching a depth of 
175 µm and 350 µm in the z-axis per mm2. Whereas an average of 1.25±0.9, 4.75±2.87 and 
13.44±7.7 of hES-NSC70+N30, hES-NSC30+N70 and hES-N reached a depth of 175 µm, 
respectively (Figure 4.13 g), none of the neurons within the hES-NSC70+N30 group but 
1.25±1.2 of the hES- NSC30+N70 and 6.5 ± 4.39 of the hES-N migrated to a depth of 350 
µm per mm2. 
To complete this slice experiment a final mixing ratio of 50% hES-N together with 50% 
proliferating nestin positive NSC was transplanted. Following 7 days in culture, migration of 
EGFP-positive neurons out of this mixed cell population was indistinguishable from the 
migration of hES-NSC70+N30 transplanted cells. These data indicate that an increase in 
neural stem/progenitor cell content within the neuronal/neural cell mixtures corresponds to a 
decrease in neuronal migration out of the transplantation site. As few as 30% of neural 
stem/progenitors cells appear sufficient to significantly reduce neuronal migration from the 
transplantation core. 
 
 
Figure 4.13: Migration of neurons out of “mixed populations”. Migration 7 days after 
transplantation on hippocampal rat slice culture of (a-b) hES-NSC70+N30, (c-d) hES-NSC30+N70 and 
(e-f) hES-N. (g) Quantification of the total number of cells reaching migration depths of 175- and 350 
µm in the z-axis per mm2 within hES-NSC70+N30 (black), hES-NSC30+N70 (grey) and hES-N (white). 
Bars represent the mean fraction of DCX-EGFP-positive migrated neurons in the different cell 
populations (* P < 0.05; ** P < 0.01). Scale bars: a,c,e 100 µm, b,d,f 50 µm. 
 
A similar result was observed following transplantation of the hES-NSC30+N70 (consisting of 
70% purified neurons and 30% proliferating, nestin positive NSC) into the striatum of adult 
rats, as performed in 4.3.3 (n=4). The total number of EGFP-positive neurons in the corpus 
callosum was quantified eight days post transplantation (see 3.8.2) and compared to the 
** 
* 
* 
* 
   Results 
65 
number of EGFP positive neurons in the corpus callosum from the transplanted hES-N, as 
well as from the transplanted hES-NSC70+N30. None of the neurons of the hES-
NSC70+N30 versus 31.3±7.64 neurons of the hES-NSC30+N70 versus 534±108.70 neurons 
of the hES-N were found in the corpus callosum (Figure 4.14). Notably, the decrease in cell 
numbers of EGFP positive cells in the corpus callosum of hES-N, correlates with the increase 
in the fraction of neural stem/progenitor cells within the transplanted cells.  
                     
Figure 4.14: In vivo migration of neurons out of “mixed populations”. Quantification of 
transplanted hES-NSC70+N30 (black), hES-NSC30+N70 (grey) and hES-N (white) found in the corpus 
callosum 8 days post transplantation. Bars represent the mean fraction of migrated cells in the 
different cell populations (* P < 0.01). 
 
4.4.3. Soluble factors with chemoattractive effect on immature neurons 
The previous results suggest that neural stem/progenitor cells attract immature neurons while 
neurons do not seem to show attraction to each other. The results from the Boyden chamber 
migration assay (see 4.4.1) further indicate that the attraction is due to at least one soluble 
factor. Therefore, the response of neurons to several soluble factors known to be present in 
the NSC niche, or described to be neuronal chemoattractants were tested. More specifically, 
DCX-EGFP-positive neurons purified by FACS (hES-N) were plated in the upper well of a 
Boyden chamber and either medium (as negative control) or plated lt-hESNSC (as positive 
control) or agarose beads pre-soaked with BDNF, EGF, SDF1, SCF, PDGF, FGF2 or VEGF 
were placed in the bottom well (see 3.7.1). In this experiment hES-N showed pronounced 
migration towards beads releasing PDGF, FGF2 and VEGF and towards plated lt-hESNSC 
(Figure 4.15). Migration of neurons was less pronounced in the presence of other factors or 
medium control.  
 
 * 
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Figure 4.15: Mini-chamber migration assay. Migration of hES-N monitored after 20 hours in culture 
towards either medium or plated lt-hESNSC or agarose beads pre-soaked with BDNF, EGF, SDF1, 
SCF, PDGF, FGF2 or VEGF. Bars represent percentage of migrated neurons (* P < 0.03; Statistical 
significance was determined in relation to medium control). 
 
4.4.4. Expression profile of chemoattractants and their receptors in neural 
stem/progenitor cells and immature neurons 
To determine whether the previously tested chemoattractants and their respective receptors 
are expressed by neural stem/progenitor cells and/or immature neurons, RT-PCR using RNA 
isolated from neural stem/progenitor cells and hES-N, respectively were performed. The 
expression profile revealed that neural stem/progenitor cells strongly express transcripts for 
BDNF, EGF, SCF, PDGF (isoforms B, C and D), FGF2 and VEGF (Figure 4.16 a). In contrast 
hES-N showed weak expression of the transcripts for EGF, SCF, PDGF (isoforms A, B, C 
and D), FGF2 and VEGF and a strong expression for BDNF. Furthermore, hES-N strongly 
express transcripts for the BDNF receptor trkB, the SCF receptor c-kit, the PDGF receptors α 
and β, the FGF receptors 1 to 4 and the VEGF receptors Flt1, Flk/KDR and Flt4, as well as 
the co-receptor NRP1 (Figure 4.16 b). With exception of PDGF receptor α and β, FGF 
receptor 4 and the VEGF receptor Flk/KDR, transcripts for the above mentioned receptors 
were also expressed by the neural stem/progenitor cells (Figure 4.16 b). These data show 
that several soluble chemoattractants are expressed in neural stem/progenitor cells, whereas 
neurons express the receptors associated to these factors. Considering the significant 
chemoattractive effect of VEGF, FGF2 and PDGF observed in the chamber migration assay 
(Figure 4.15), these factors represent interesting candidates to test for a role in core 
formation of progenitor-containing neural grafts.       
  *   *   * 
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Figure 4.16: Expression of chemoattractants and their respective receptor sets in neural 
stem/progenitor cells and immature neurons. RT-PCR analysis of the expression of the RNA 
transcript for (a) chemoattractants and (b) the respective receptor sets in neural stem/progenitor cells 
and “purified neurons” (hES-N). Human fetal brain tissue (19 weeks of gestation) (FB) served as 
control.   
 
 
4.4.5. Interaction with chemoattractants expressed by neural stem/progenitor cells in 
vitro  
To assess whether FGF2 and VEGF play a role in preventing migration of immature neurons 
out of a cell mixture with neural stem/progenitor cells, different agents known to interfere with 
these signaling pathways were tested. SU5402 is a known pharmacological inhibitor of the 
tyrosine kinase activity of FGF receptor 1, as well as FGF-induced phosphorylation of the 
downstream kinases ERK1 and ERK2 (Mohammadi et al., 1997). To interfere specifically 
with the VEGF pathway an anti-human VEGF receptor 2 antibody (VEGF R2-AB), known to 
neutralize the bioactivity of VEGF receptor Flk/KDR (Ferrara & Davis-Smyth, 1997) was 
chosen. Furthermore the recombinant human protein endostatin, a cleavage product of 
collagen XVIII (Marneros & Olsen, 2005), which has been reported to have anti-angiogenesis 
effects (O'Reilly et al., 1997; Marneros & Olsen, 2001) and which inhibits endothelial cell 
migration in response to FGF2 and VEGF (Eriksson et al., 2003) was tested, although, no 
effect on neural cells was so far reported.  
To study whether any of these three molecules (SU5402, VEGF R2-AB or endostatin) had an 
effect on the neuronal migration of immature neurons in the presence of neural stem/ 
progenitor cells, Boyden chamber assays were performed. HES-NSC70+N30 which pre-
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incubated for 30 minutes in 30 µl CytoconTMBuffer II with either 20 µM SU5402, 10 µl VEGF 
R2-AB stock solution (see 2.5.1), 2 µl endostatin stock solution (see 2.5.1) or with the 
equivalent solvents, were placed in the upper well. The lower wells contained medium and 
either plain agarose beads or agarose beads soaked with PDGF as attractant. A significantly 
enhanced migration of immature neurons towards media was observed when pre-incubating 
the cell mixture with the VEGF R2-AB or endostatin. The chemoattractive gradient, which 
was caused by the agarose beads releasing PDGF, additionally enhanced the effect of the 
VEGF-R2-AB and endostatin pre-incubation (Figure 4.17). In contrast the SU5402 did not 
show a significant effect on the migration of immature neurons compared to the untreated 
control cell population. 
 
                  
 
Figure 4.17: Mini-chamber migration of hES-NSC70+N30 in the presence of SU5402, VEGF R2-
AB or endostatin. Bars represent the percentage of migrated neurons after 20 hours in culture 
towards medium or a chemoattractant either with or without SU5402, VEGF R2-AB or endostatin 
treatment. Cell numbers were normalised to the number of EGFP positive plated cells (* P ≤ 0.02; 
statistical significance was determined in relation to the control).  
 
The data of this Boyden chamber assay suggest that interfering with chemoattractive factors 
expressed by neural stem/progenitor cells can partially influence the auto-attractive effect of 
a mixed neural/neuronal population.  
 
 
 
 
 
*  *   * 
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4.4.6. Interaction with chemoattractants expressed by neural stem/progenitor cells on 
hippocampal rat slice cultures  
The previous results showed that pre-incubation of hES-NSC70+N30 with endostatin 
resulted in the most prominent enhancement of migration in a Boyden chamber assay (see 
4.4.4). To further investigate whether endostatin can also interfere with the chemoattractive 
effect of neural stem/progenitor cells on immature neurons in a context closer to an in vivo 
situation, hippocampal rat slice culture experiments were performed. HES-NSC70+N30 were 
pre-incubated for 30 minutes in 30 µl CytoconTM-Buffer II with either 2 µl stock solution 
endostatin (n=9) or with 2 µl of the solvent of endostatin (citric-phosphate buffer) as control 
(n=9), and then deposited on the entorhinal cortex of hippocampal slice cultures. HES-N 
were transplanted as positive control (n=9). In this experiment, slices were further cultured for 
18 days after deposition of the cells as a clearer significant difference of migration was 
expected with extended co-culture duration. 1 µl/ml endostatin stock solution was 
continuously applied every day to the slice media. When analyzing the cultures at day 18, 
endostatin treated cells showed an enhanced migration horizontally over the slice, compared 
to the control population. Yet this migration appeared more limited than the migration of 
purified neurons (Figure 4.18 a,c,e). Migration of single EGFP-positive neurons up to 800 µm 
away from the transplantation core was frequently observed in the endostatin treated 
transplants, whereas the cells from the untreated control transplants never migrated further 
than 500 µm from the transplantation core. This enhancement of migration was also present 
along the z-axis, as the endostatin treated cells frequently reached depths of 350 µm (Figure 
4.18 d) whereas the non-treated cells never exceed 200 µm (Figure 4.18 b). These data, 
although preliminary, suggest that interference with the chemoattraction between neural 
stem/progenitor cells and immature neurons via applying endostatin might indeed enhance 
the migration and integration capacity of mixed neural grafts. However, when compared to 
hES-N only, the migration and integration capacity of endostatin treated cells appeared to be 
only mildly enhanced, indicating that by solely applying endostatin, a comparable 
enhancement of migration as seen in the hES-N might not be achievable (Figure 4.18 e-f).  
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Figure 4.18: Neuronal migration of a hES-NSC70+N30 control population, a hES-NSC70+N30 
endostatin treated population and hES-N on hippocampal rat slice cultures. 18 days after 
transplantation (c,d) endostatin treated cells showed an enhanced migration and integration capacity 
as compared to (a,b) control cells both in the xy- as well as the z-axis. However, migration as 
observed in (e,f) hES-N could not be achieved. Slices (a,c,e) were DAPI and EGFP stained post 
fixation. Scale bars: a,c,e 500 µm. 
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5. DISCUSSION 
5.1. Genetic lineage selection of hES cell derived neurons  
A fundamental prerequisite for CNS cell replacement strategies is the generation of donor 
cells in high purity to avoid the contamination risk with insufficiently differentiated cells 
leading to tumour formation. In order to achieve this, tools for the generation of pure lineage 
specific cell types, or of specific postmitotic sub-types need to be developed. In the present 
study a doublecortin-based lineage selection approach has been established for the 
enrichment of human ES cell derived immature neurons.   
 
5.1.1. Surface bound versus genetic lineage selection  
Several markers have been so far explored as potential lineage selection candidates for the 
isolation of specific cell types. Surface bound epitopes are widely used for the selection of a 
cellular subtype, especially in the field of the hematopoietic research (Herzenberg et al., 
2002; Perez & Nolan, 2006). Immuno-isolation of neural lineages has successfully been 
applied to neurons (Jungling et al., 2003; Schmandt et al., 2005) and glia (Malatesta et al., 
2000) in the mouse system. Recently, Pruszak and colleagues published a comprehensive 
analysis on the applicability of surface marker-based selection of human embryonic stem 
cell-derived neural lineages (Pruszak et al., 2007). Application of surface markers for lineage 
selection has several advantages, for instance the isolation of cell types without genetic 
manipulation, and the easy application to any cellular source. However, most of the known 
surface markers lack specificity. For example N-CAM is expressed in neural progenitors and 
neurons but also in other cell types such as hematopoietic natural killer (NK)-cells or 
neuroendocrine cells (Seldeslagh & Lauweryns, 1997; Koch et al., 2006; Pruszak et al., 
2007). NG2 is expressed in oligodendrocyte progenitors (Polito & Reynolds, 2005) but also in 
melanocytes (Lim et al., 2007). CD133 is expressed in NSCs (Uchida et al., 2000) but also in 
several stem cells of different origin (Jaatinen et al., 2006). Moreover, the surface marker-
based selection strongly depends on the specificity of the individual antibodies and is 
associated with high costs when facing large-scale applications. 
Genetic lineage selection either by a fluorescent protein or by an antibiotic resistance gene is 
another widely used method. Transgenic murine ES cells and mouse strains harbouring a 
marker gene have been successfully employed to monitor and isolate multiple cell types 
including neuroepithelial progenitors (Aubert et al., 2003), neurons (Wernig et al., 2002) or 
defined neuronal subtypes (Wichterle et al., 2002; Thompson et al., 2006). Random insertion 
of specific promoter-EGFP constructs proved to be a reliable tool for lineage selection in a 
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cell culture based system (Roy et al., 2000a; Wang et al., 2000; Glaser et al., 2005; 
Schmandt et al., 2005). On the one hand, the transgene-based lineage selection has the 
disadvantage that cells need to be genetically manipulated and thereby carry artificial 
genome alterations. On the other hand, the beauty of this system lies in its reliability and 
simplicity once established. Furthermore, genetic lineage selection has proven to be highly 
specific and led to isolation of lineages, cell-types and even defined cellular sub-types 
(Herzenberg et al., 2002; Goldman, 2005). 
 
5.1.2. Doublecortin as candidate marker for the selection of immature neurons 
The present study investigated and further characterized a candidate marker for a genetic 
lineage selection approach to specifically isolate immature neurons derived from human ES 
cells. Doublecortin (DCX), a 40 kDa microtubule-associated protein (Francis et al., 1999; 
Gleeson et al., 1999; Taylor et al., 2000) appeared to be an interesting potential candidate 
marker, as it is known to be exclusively expressed in newborn and immature neurons in the 
developing and adult brain in vivo (see 1.2.3) (Chelly, 1998; Gleeson et al., 1998; LoTurco, 
2004; Rao & Shetty, 2004; Couillard-Despres et al., 2005; Bernreuther et al., 2006). In 
addition, DCX is one of the earliest markers for neuronal differentiation (Magavi & Macklis, 
2008), and thus offers the possibility to identify and isolate neurons in a very early 
developmental state. The immature state of neurons is particularly important for a lineage 
selection approach because of several reasons. First of all, recent studies showed that only 
immature neurons survive the mechanical manipulation, which is fundamental for FACS-
based isolation, i.e. enzymatic digestion to single cell suspensions, and pressure during the 
sorting procedure (Pruszak et al., 2007). Secondly, this differentiation state is important in the 
context of reconstructive approaches, as only immature neurons possess sufficient plasticity 
to survive and integrate after transplantation (Bjorklund & Lindvall, 2000; Brederlau et al., 
2006).  
In this study, the exclusive expression pattern of DCX in immature neurons could be 
confirmed in the human ES cell-based cell culture paradigm of lt-hESNSC (see 1.1.3). This 
was shown by the co-expression of DCX with markers expressed in immature neurons such 
as beta-III tubulin, the lacking co-expression with the neural progenitor marker nestin and the 
barely detectable co-expression with the more mature neuronal marker NeuN (see Figure 
4.1). Additionally, GFAP-positive astrocytes or O4-positive oligodendrocytes did not express 
DCX. These data revealed that the observed dynamics of DCX expression in an in vitro cell 
culture system largely resemble the highly specific expression pattern of DCX in immature 
neurons in vivo. 
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5.1.3. Establishment of a DCX-EGFP lineage selection system  
Based on the specific expression of DCX in lt-hESNSC derived immature neurons, a lineage 
selection system using DCX has been established. As DCX is an intracellular marker, 
surface based immuno-isolation could not be applied. Instead, a construct carrying an EGFP 
under the control of a 3.5 kb human DCX promoter sequence (kindly provided by Sebastien 
Couillard-Després and Ludwig Aigner, see 2.4) was used to generate a DCX-EGFP lt-
hESNSC reporter cell line. One limitation of stable transfection of cell lines with constructs 
carrying a minimum consensus promoter sequence is the frequently observed background 
expression of the reporter gene due to random insertion into the genome (Glaser et al., 2005; 
Schmandt et al., 2005). In contrast to e.g. large constructs carrying up to 250 kb of the DNA 
sequence around the promoter region such as bacterial artificial chromosomes (BACs), the 
expression specificity of these small reporter constructs is strongly influenced by the locus 
they integrate in. In line with this, unspecific EGFP expression was observed in most of the 
clones generated in this study. Careful characterization of the clones to show the faithful co-
expression of the DCX protein and the EGFP transgene was therefore an essential 
prerequisite for the further applicability of the established cell lines. The comparative analysis 
of the expression of endogenous DCX and EGFP identified four clones which faithfully reflect 
an immature neuronal phenotype by the EGFP transgene expression (see Figure 4.2). The 
established clones showed to have a constant proliferation and differentiation potential over 
multiple passages and could be frozen in liquid nitrogen without loss of their specific EGFP 
transgene expression.  
Although FACS for neural cells has been used in studies of animal models and even for hES 
cell derived neurons (Pruszak et al., 2007) it has not been standardized for neuronal cell 
types most likely due to the problems in using such fragile cells. An optimal model should 
guarantee high efficiency, high purity as well as maximum post FACS survival. As discussed 
before the broad expression of DCX in an immature neuronal state was a major prerequisite. 
Limited efficiencies and restricted survival observed in other studies were often due to the 
fact, that the chosen markers stained later developmental states or just subsets of neurons 
(Dittgen et al., 2004; Hedlund et al., 2007). However, also within the DCX-EGFP system 
efficiencies had to be traded against the survival. Longer differentiation times of the DCX-
EGFP lt-hESNSC reporter cell line resulted in an increase in DCX-EGFP-positive cells but 
also increased the maturation stage of the DCX-EGFP-positive neurons. Thus the 
appropriate time point of differentiation had to be defined at which DCX-EGFP-positive cells 
were present in sufficient numbers, yet still immature enough to survive the mechanical 
manipulation associated with the sorting procedure. Differentiation studies suggested day 
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8±1 as an optimal time window as at this time point in fact, on average 31±2.8% of the cells 
expressed the DCX-EGFP transgene, while less than 50% of them co-expressed the more 
mature neuronal marker MAP2ab (see 4.1.3). At this time point the sorting procedure was 
highly efficient. Starting by day 8±1 of differentiation from three to four 10 cm cell culture 
plastic dishes with a total of 8 x 107 cells, a typical FACS session of 4 to 5 hours yielded 
more than 2 x 107 purified neurons. Sorted cells were amenable to replating; thus they 
survived the sorting procedure. Characterisation of replated neuronal cells showed that over 
95% of them co-expressed beta-III tubulin and EGFP, indicating that also high purity could be 
achieved by the DCX-EGFP based lineage selection. 
Thinking about further applications of a DCX-EGFP lineage selection such as transplantation 
studies with follow up times of several months, one limitation of a DCX-EGFP reporter line is 
that the EGFP transgene might be down-regulated during neuronal maturation in vivo, 
making it more difficult to identify transplanted cells thereafter. To overcome this problem a 
double reporter line was established expressing EGFP under control of a ubiquitous 
promoter and DsRED2 under control of the DCX promoter (DCX-dsRED2:PGK-EGFP). The 
DCX-dsRED2:PGK-EGFP reporter line also showed faithful overlap of the dsRED2 reporter 
and the endogenous DCX protein. Most importantly DCX-DsRED2 positive cells could be 
distinguished by FACS from only EGFP-positive cells and DCX-dsRED2 positive neurons 
could be isolated in comparable purity to DCX-EGFP-positive neurons (Figure 4.4). 
 
5.1.4. Characterization of the DCX-EGFP purified neurons 
For further use of the DCX-EGFP purified neurons in various biological and pharmacological 
applications it was of major importance to control that neither the genetic manipulation, nor 
the FACSorting had an influence on the characteristics and the functional properties of the 
purified cells. To that end immunocytochemistry-based phenotype analysis and functional 
characterisation of DCX-EGFP purified neurons were required.  
Immunocytochemistry-based phenotype analysis of the purified neurons showed that most 
neurons acquired a GABAergic phenotype. The huge proportion of GABAergic differentiation 
is in agreement with the notion that growth factor-expanded neural precursors tend to acquire 
a mainly GABAergic phenotype (Jain et al., 2003; Conti et al., 2005; Koch et al., 2006; 
Zhang, 2006) and with the data of Koch and co-workers (Koch et al., in revision) who in detail 
investigated in the differentiation pattern of lt-hESNSC. Thus neither the genetic manipulation 
of the lt-hESNSC with the DCX-EGFP construct nor the FACSorting seemed to significantly 
influence the neuronal phenotype of the cells. However, it would be of major interest whether 
other neuronal phenotypes such as glutamatergic neurons, serotoninergic neurons, 
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dopaminergic neurons or motoneurons could be isolated using the same parameters 
established for the mainly GABAergic cells. Future experiments using extrinsic morphogens 
or intrinsic key transcription factors to guide lt-hESNSC towards these specific neuronal 
subtypes in combination with the DCX-EGFP lineage selection approach might then also 
facilitate the isolation of these important disease-related cell types.  
In addition to the immunocytochemical analysis, functional characteristics of the selected 
cells were assayed using whole-cell patch-clamp recordings. The analysis revealed that the 
purified neurons were able to develop into mature and functional neurons. They expressed 
sodium and different kinds of potassium channels, were able to generate repetitive action 
potentials upon long-lasting depolarisation and displayed surface expression of 
AMPA/kainate and GABAA receptors as a prerequisite for the formation of glutamatergic and 
GABAergic synapses and evoked PSCs. After placing the sorted neurons onto hippocampal 
rat slices, a paradigm, which promotes long-term survival and functional maturation of ES 
cell-derived neurons (Benninger et al., 2003) postsynaptic currents could be identified 
indicating functional connections with the slice. These studies revealed that genetic 
manipulation and FACSorting do not impair the functional properties of the cells. 
Interestingly, mature ion channel and repetitive action potential generation could be 
demonstrated as early as four weeks post sorting. Long maturation times of human ES cell 
derived neurons are a major problem for studying neuronal networks in vitro. Recent 
publications show that network generation is depending on mature astrocytes and typically 
requires eight weeks after the initiation of differentiation by growth factor withdrawal (Johnson 
et al., 2007; Wu et al., 2007). To facilitate long-term survival, DCX-EGFP selected neurons 
were also placed on astrocytic layers or hippocampal slice cultures. However, network 
integration and postsynaptic currents were detectable as early as four weeks after sorting 
(i.e. five weeks after growth factor withdrawal) in 8 out of 9 cells. Further experiments are 
needed to consolidate this observation. One might speculate that the very early appearance 
of mature functional properties is due to the fact that DCX-EGFP selected cells were placed 
on the slices as pure neuronal population, which might accelerate maturation.  
 
In conclusion, a DCX-EGFP based lineage selection system is a robust method to isolate 
immature neurons out of differentiating lt-hESNSC cultures and the purification of DCX-
EGFP-positive neurons does not impair the functional properties of the cells.  
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5.2.  Efficient cryopreservation of purified human neurons  
For subsequent applications of hES cell-derived neurons in neural restoration or 
pharmacological screening, it would be desirable to have purified young neurons stored and 
available on demand. Unfortunately, mature neurons are profoundly sensitive to 
cryopreservation. The immature state of the selected DCX-EGFP-positive neurons was an 
important prerequisite for their amenability to cryopreservation.  
Commercially available freezing media only led to moderate post freezing survival of the 
cells. To optimize cryopreservation of DCX-positive neurons a formulation was composed 
which was supplemented with myo-inositol and polyvinyl alcohol. Myo-inositol is found in 
cyanobacteria, algae, fungi and plants, where it functions as an osmolyte to tolerate or avoid 
freezing (Kostal & Savory, 1996; Yancey, 2005). Polyvinyl alcohol is well known to prevent or 
delay ice nucleation (Asada et al., 2002). However, even with the optimized freezing medium 
post-freeze survival remained < 48%, and many cells did not survive the first 24 hours after 
thawing. Thus, pre-incubation of the cells with the general caspase inhibitor z-VAD-fmk was 
included, which resulted in a further increase in post-thaw cell survival rate. Apoptosis 
mediated through a caspase-dependent mechanism has been shown to be responsible for a 
significant cell loss following cryopreservation of hES-cells (Heng et al., 2006; Heng et al., 
2007). In addition, NSCs undergo apoptosis via the mitochondrial pathway with caspase-3 
serving as the executioner caspase in the apoptotic machinery (Sleeper et al., 2002). 
Although the general caspase inhibitor z-VAD-fmk used in this study has a half-life of less 
than 24 hours in cell culture media (Alessandri et al., 2006), this was sufficient to decrease 
caspase-3 and -7 activity in the z-VAD-fmk pre-treated cells as measured in the caspase-3/7 
assay performed 20 hours post thawing. Thus the general caspase inhibitor z-VAD-fmk might 
protect the cells from undergoing apoptosis during the cryopreservation process and within 
the first hours after thawing and plating. However, pre-incubation with a pharmacological 
caspase inhibitor might also impair possible read-outs in pharmacological studies. To 
analyze whether the caspase inhibition is temporary, staurosporine treatment of the cells was 
applied four days after thawing, showing no difference in induced apoptosis between z-VAD-
fmk-treated and non-treated cells. Therefore, the z-VAD-fmk treatment should not impair 
pharmacological toxicity studies in cryopreserved hES cell-derived neurons. Furthermore, 
cryopreserved, thawed and replated neurons co-expressed beta-III tubulin and EGFP and, 
most importantly, maintained functionality after thawing and further culturing, comparable to 
their non-cryopreserved counterparts. Another important aspect for further application is that 
cryopreserved and thawed neurons survive transplantation into the neonatal rat brain. 
Transplanted DCX-EGFP expressing cells showed distribution in a variety of host brain 
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regions where they appeared to morphologically integrate. Furthermore, they displayed a 
neuronal phenotype with delineation of neurites (see 4.2.2). Thus, cryopreservation of DCX-
EGFP-purified postmitotic immature neurons appears to be highly efficient and does not 
impair the functional properties of the cells. Further electrophysiological studies are 
necessary to really prove that the cryopreserved neurons can develop functional properties in 
vivo and integrate into the existing circuitries. 
 
5.3.  Enhanced migration of human neurons as pure population 
In the developing as well as in the adult brain DCX expression is closely associated with an 
immature migratory neuronal phenotype (Chelly, 1998; des Portes et al., 1998; Gleeson et 
al., 1998; Francis et al., 1999; LoTurco, 2004; Rao & Shetty, 2004; Couillard-Despres et al., 
2005; Bernreuther et al., 2006). Analysis of genetically induced malformations in the 
mammalian brain showed that DCX plays an essential role in the regulation of neuronal 
migration, as mutations of this gene cause disorganization of the layers in the cerebral cortex 
(see 1.2.3) (Feng & Walsh, 2001). Thus, an interesting question was whether the DCX-EGFP 
purified human neurons have a strong migration potential. Indeed, when studying the 
migration capacity of DCX-EGFP-positive neurons in a variety of in vitro and in vivo migration 
assays, DCX-positive neurons appeared to be highly migratory.  
 
5.3.1. Migration of DCX-EGFP positive neurons as pure population and within a neural 
stem/progenitor cell containing population 
In a matrigel and transfilter-based migration assay DCX-EGFP purified neurons (hES-N) 
showed strong migration towards the bottom well of the transwell filter and distributed across 
a large area on the gel matrix. In contrast, the non-purified control population (hES-NSC+N) - 
consisting of about 30% DCX-EGFP-positive immature neurons and 70% other cell types, 
most of which expressing nestin - displayed only limited migration in the transwell filter assay 
and formed sphere-like cell clusters on the gel matrix (see Figure 4.9). This observation was 
interesting, as it indicates that DCX-EGFP-positive neurons have an enhanced migratory 
potential as a purified population only. In contrast, the corresponding DCX-EGFP-positive 
neurons within the non-purified control population (hES-NSC+N) did not show such a strong 
migratory behaviour although they should in principle have the same migration potential as 
the purified neurons.  
Similar results were received when transplanting hES-N or hES-NSC+N on hippocampal rat 
slice cultures. The hES-N showed strong migration and integration potential whereas the 
 Discussion 
78 
hES-NSC+N only displayed limited migration and formed the already in the matrigel assay 
described sphere-like clusters with axonal outgrowth only (see Figure 4.10). 
To ensure that the observations from the in vitro migration assays were not only in vitro cell 
culture artifacts, in vivo migration studies following transplantation of hES-N and hES-NSC+N 
into the brain of adult rats were performed. Several previous studies analysed the migration 
and integration potential of hES cell-derived neurons in vivo. Former studies, in which hES 
cell-derived neural cells were transplanted into rat brains, described clusters of donor cells at 
the site of engraftment one week after transplantation, the so called transplantation cores 
(Reubinoff et al., 2001). Tabar (Tabar et al., 2005) and co-workers investigated in vivo 
migration of hES cell-derived neural precursors transplanted into the rostral migratory stream 
of adult rats and found that about one fourth of the transplanted cells migrated out of the 
transplantation core within 11 weeks. In comparison, when transplanting DCX-EGFP purified 
cells into the striatum of adult rats, a large amount of the cells migrated out of the 
transplantation core within 8 days. Similar results have been achieved following 
transplantation into the rostral migratory stream, where transplanted neurons morphologically 
orientated to and migrated towards the olfactory bulb within 8 days (see Figure 4.11). 
However, when a mixed population (hES-NSC+N) was transplanted it was observed that the 
cells formed densely packed clusters at the transplantation site with only restricted migration 
of DCX-EGFP-positive neurons out of the transplantation core.  
Cluster formation and limited migration and integration have been topics in neurobiological 
research for many years. A major challenge in therapeutic transplantation of donor cells for 
neural damage repair is to achieve functional integration of the donor cells into the host 
tissue. Limited integration due to restricted emigration of the transplanted cells, which mainly 
remain located at the grafted site (Guzman et al., 2008) is a widely discussed issue (see 
1.1.3) and described in many different studies using primary cells or ES cell derived neural 
progeny (Fricker et al., 1999; Tabar et al., 2005; Roy et al., 2006). It is argued that this core 
formation of neural transplants is due to physical or molecular barriers caused by glial 
scarring at the lesion site following transplantation (Reier et al., 1983; Rudge & Silver, 1990). 
Successful axonal outgrowth is known to be associated with minimal up-regulation of 
proteoglycans within the extracellular matrix of reactive glial cells at the transplantation site 
(Davies et al., 1997). This might also restrict migration of transplanted neuronal progenitors. 
It was suggested that the up-regulation of proteoglycans might be avoided by using micro-
transplants that minimize scarring by injecting minimal volumes of dissociated cells (Nikkhah 
et al., 1995; Davies et al., 1997). Glial scarring at the transplantation site is, however, not the 
only possible explanation for the formation of transplantation cores. As in the transplantation 
paradigm used in the present study, the total number of transplanted hES-N or hES-NSC+N 
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cells was equal, as was the transplantation methodology. The intriguing question arising at 
this point was why immature neurons only migrate as purified populations, whereas they 
display only very restricted migration when mixed with other cell types, most of which 
expressing nestin. As there must be factors involved in causing core formation other than 
transplantation size or glial scar formation, one potential factor might be direct or indirect cell-
cell-interactions between the different transplanted cell types.  
 
5.4.  Mechanisms causing core formation of neural stem/progenitor cell 
containing transplants 
Experiments performed in the context of this study provided first evidence that one possible 
putative mechanism underlying cluster formation and restricted emigration of donor neurons 
from neural stem/progenitor-containing grafts might be chemoattractive interactions between 
the transplanted neural stem/progenitor cells and immature neurons. In vitro, human neurons 
showed a pronounced migration towards undifferentiated lt-hESNSC in a transfilter migration 
assay (see Figure 4.12) indicating that lt-hESNSC express at least one soluble factor having 
a chemoattractive effect on neurons. In addition, migration assays of cell mixtures composed 
of neural/neuronal cells in different ratios in rodent CNS tissue revealed that the extent of 
neuronal migration away from the core appears to be highly dependent and inversely 
proportional to the number of neural stem/progenitor cells present in the transplanted 
population, with a proportion of about 30% neural stem/progenitors being sufficient to almost 
completely inhibit migration away from the transplantation site. According to these data it 
appears that interaction between neural stem/progenitors and neurons might indeed be one 
reason for the observed core formation in neural transplants. One possibility to avoid core 
formation would thus be to transplant purified immature neurons (hES-N). However, 
considering that most neural transplants from either ES cells or from fetal tissue contain a 
considerable amount of neural stem/progenitor cells, and taking into account that 
establishing a lineage selection system to purify immature neurons might not be feasible for 
primary cultures, it would be of great value to gain more insight into the mechanisms 
responsible for this suggested “auto-attraction” phenomenon. Once uncovered, interference 
with such auto-attractive mechanisms may be effectively used to enhance neuronal migration 
and integration of transplanted neural populations without the need of lineage selection. 
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5.4.1. Analysis of chemoattractive factors and associated receptors in neural 
stem/progenitor cells and immature neurons 
Considering a possible interaction between in vitro generated neural stem/progenitor cells 
and immature neurons based on indirect cell-cell signalling, one might speculate that this 
signalling shares similarities to those signals present in the NSC niche. In vivo migration of 
immature progenitors out of the NSC niche is regulated by a complex interaction of intrinsic 
and extrinsic factors including repulsive and attractive cues (Fuchs et al., 2004). The 
interplay of the extrinsic and intrinsic cues modulates the NSC niche, allowing NSCs to 
persist under physiological normal conditions and recruiting immature progenitors to a 
specific site under challenging physiological conditions (Scadden, 2006). Intrinsic factors and 
attractants, which function in the NSC niche in vivo, might also be involved in building up a 
“niche-like structure” within the grafts of in vitro generated NSCs. This might result in an 
chemo-attraction of the neurons by the neural stem/progenitor cells causing the observed 
core formation phenomenon. In the literature, many factors have been described to have a 
chemoattractive effect on neurons including VEGF (Zhang et al., 2003), GDNF (Paratcha et 
al., 2006) and FGF (Shirasaki et al., 2006). The microenvironmental niche signals comprise a 
number of those factors including VEGF and FGF2 (Doetsch, 2003). VEGF was originally 
identified as a major mediator of angiogenesis (Carmeliet et al., 1996). Recently VEGF was 
also shown to stimulate neurogenesis (Jin et al., 2002; Fabel et al., 2003; Cao et al., 2004; 
Schanzer et al., 2004) and to act as a chemoattractant for FGF2 stimulated neural 
progenitors (Zhang et al., 2003). In addition, previous studies suggest that both vascular cells 
and glial cells which both express VEGF and FGF2 (Heine et al., 2005) may serve as a niche 
for NSCs (Song et al., 2002; Shen et al., 2004). 
In the context of this study different potential chemoattractants for immature neurons were 
tested in a Boyden chamber assay (see Figure 4.15). In addition, mRNA expression levels of 
the tested factors and the corresponding receptors were analyzed in neural stem/progenitor 
cells and immature neurons by RT-PCR (see Figure 4.16). At least two potential candidate 
factors of which one or both might be involved in the auto-attraction phenomenon observed 
between neural stem/progenitor cells and derived neurons were identified, namely FGF2 and 
VEGF. Those two showed high expression in the neural stem/progenitor population, high 
expression of the corresponding receptors in the DCX-EGFP purified neurons and had a 
significant chemoattractive effect on DCX-EGFP-positive neurons in the Boyden chamber 
migration assay.  
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5.4.2. Interference with the chemoattractive mechanisms between neural 
stem/progenitor cells and immature neurons in vitro  
In order to enhance neuronal migration out of mixed neural/neuronal populations one might 
have to interfere with the suggested auto-attraction between neural stem/progenitor cells and 
immature neurons without completely inhibiting neuronal migration. This approach should 
ideally, on the one hand reduce the auto-attractive mechanisms that keep the neurons in the 
transplantation cores and inhibit their migration from the grafts and, on the other hand 
achieve that the neurons become more susceptible to other environmental attractants. Three 
different potentially interesting candidate molecules were tested. One was SU5402, a known 
inhibitor of the tyrosine kinase activity of FGF receptor 1 as well as FGF-induced 
phosphorylation of the downstream kinases ERK1 and ERK2 (Mohammadi et al., 1997). The 
second candidate molecule was the anti-human VEGF receptor 2 antibody (VEGF R2-AB), 
which neutralizes the bioactivity of VEGF receptor Flk/KDR (Ferrara & Davis-Smyth, 1997) 
which could be detected in immature neurons by RT-PCR (see Figure 4.16). Finally, 
endostatin, a 20 kDa C-terminal proteolytic fragment of collagen XVIII (Marneros & Olsen, 
2005) was tested. This compound has been found to be a potent inhibitor of angiogenesis. In 
vitro, endostatin specifically inhibits endothelial cell proliferation (O'Reilly et al., 1997). In 
vivo, the systemic administration of recombinant endostatin resulted in growth inhibition or 
regression in a number of different tumour models (O'Reilly et al., 1997; Bergers et al., 1999; 
Dhanabal et al., 1999; Shi et al., 2002). Functionally, endostatin was also suggested to be an 
inhibitor of the FGF2 and VEGF chemoattractant-mediated cell migration of endothelial cells 
(Yamaguchi et al., 1999; Eriksson et al., 2003). However the exact mechanisms mediating 
these effects are barely understood. It was not yet clear whether endostatin is inhibiting the 
migration in response to FGF2 and VEGF only or chemoattractant-mediated migration in 
general. In addition, no data exists on whether endostatin has similar effects on neural cells. 
Thus, endostatin appeared to be an interesting candidate to be tested in the present work 
with regard to a possible inhibitory function in chemoattractant-mediated auto-attraction. 
To analyse the role of the different compounds in vitro, the substances were applied in a 
transfilter migration assay in which neuronal migration out of a neural/neuronal cell mixture 
was measured (see Figure 4.17). This study revealed that neural/neuronal cell mixtures 
treated with SU5402 did not show enhanced neuronal migration. This can have different 
reasons. First of all, it might be that the attraction of immature neurons towards FGF2 is not 
mediated via the FGF receptor1. Secondly, SU5402 might also inhibit other pathways 
essential for migration. Finally, it could also be that FGF2 is only playing a minor role in the 
suggested auto-attraction phenomenon. Treating the cell-mixture with an antibody binding to 
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the VEGF receptor Flk/KDR significantly increased migration in a transfilter assay. This 
finding would support the hypothesis that VEGF is involved in the auto-attraction 
phenomenon and that the chemoattractive effect of VEGF is at least in part mediated via the 
VEGF receptor Flk/KDR. The strongest enhancement in migration could be monitored when 
applying endostatin (see Figure 4.17). The effect could be augmented by adding an 
attractant other than FGF2 or VEGF such as PDGF to the lower well. This suggests that 
endostatin does not interfere with chemoattractant-mediated migration of neural cells in 
general. However, the exact role of the protein in cell migration remains unclear. Hence, by 
interacting with the chemoattraction between neural cell populations and their neuronal 
progeny it might be possible to enhance neuronal migration and integration.  
However, preliminary data on the effect of endostatin on transplanted neural/neuronal 
populations on hippocampal rat slice cultures showed an only mild enhancement in neuronal 
migration out of the transplantation core (see Figure 4.18). This might be explained by a 
balance between intrinsic cell-cell interaction restricting neuronal migration out of 
neural/neuronal mixed cell transplants and extrinsic factors such as attractive cues recruiting 
transplanted immature neurons to specific sites. Interacting with some of the intrinsic 
mechanisms only by e.g. endostatin treatment might not be sufficient to enhance neuronal 
migration out of a mixed neural/neuronal population in a tissue context. An additional 
attractor might be necessary to mediate migration away from the core. Previous studies 
already showed that implanted neural progenitors migrate towards a stroke region (Imitola, et 
al., 2004) and that this migration was directed due to signals provoked by the stroke 
(Guzmann, et al., 2007). One attractive experiment would therefore be the transplantation of 
a cell mixture of neural stem/progenitor cells and immature neurons in the vicinity of a lesion 
or stroke model in vivo. In such an experiment, the transplanted animals might be also 
treated systemically with endostatin. The lesion or stroke might provide sufficient attractants 
for the transplanted and endostatin treated cells to overcome the remaining auto-attractive 
effect, thereby, enabling enhanced targeted migration.  
 
5.5. Perspective 
The here developed protocol for the DCX-EGFP based lineage selection represents a useful 
tool for the production of infinite numbers of pure immature human neuronal cultures. These 
cells are promising candidates for future transplantation strategies, basic research, and 
model systems for screening approaches. The cell-based reconstruction within the CNS 
depends on neuronal precursors that have the potential to migrate and integrate into the 
existing neuronal circuitries. Their post-mitotic stage of differentiation minimizes the risk of 
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tumour formation, an issue that always has to be considered talking about ES cells as donor 
populations. The purified cultures could also be used to study gene expression patterns or 
biochemical pathways specifical for human neurons. In principle, the DCX-EGFP based 
neuronal lineage selection approach should also be applicable to other human ES cell-like 
cells. In this context, recently described alternative sources of pluripotent cells from adult 
germline (Conrad et al., 2008) or of reprogrammed somatic cells (Takahashi & Yamanaka, 
2006; Okita et al., 2007; Wernig et al., 2007) which have an attractive potential for 
regenerative medicine and pharmaceutical studies might further extend potential applications 
of this technology. As an example, applying the DCX-EGFP based lineage selection on a 
patient specific iPS cell line, which carries a gene alteration for a neurodegenerative disease 
might enable to study the disease pathogenesis specifically in altered human neurons. 
Moreover, the DCX-EGFP lineage selection technique coupled with the newly established 
efficient cryopreservation protocol provides interesting perspectives for the use of DCX-
EGFP-selected cells in screening functional effects of pharmacological compounds, as it 
opens the possibility for having functional human neurons on demand.  
The availability of a pure neuronal population enables to investigate neuronal migration in a 
highly controlled manner. The findings that neural stem/progenitor cells inhibit neuronal 
migration and the identification of potential candidates involved in the underlying mechanism, 
will be of great value for the field of neuronal transplantation, possibly leading to protocols 
facilitating enhanced integration of cells in the host tissue. Endostatin, an antiangiogenetic 
drug, was suggested to enhance the migration potential of neuronal cells in a transfilter 
assay. As many statins are available, this group of drugs applied to the patient might also 
enhance the migration and integration of neural transplants in vivo. Further studies will be 
required to determine whether and to what extent neural stem cell cores can be avoided by 
interacting with the discovered cell-interaction, as well as to identify to what extent the 
migrating cells become functionally active, and acquire region-specific properties. As the 
discovered cell-interaction do not seem to be the only attractants functioning in core 
formation, additional pathways and/or receptors have to be investigated. While it is clear that 
application to different disease models is required before considering potential clinical 
applications, these data suggest that interacting with the auto-attraction in neural grafts might 
lead to methods enabling enhanced integration into the host tissue and therefore represents 
a promising approach for neural repair. 
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6. ABSTRACT 
In this study, a human Doublecortin (DCX) promoter-based lineage selection strategy is 
presented for the generation of purified human embryonic stem (hES) cell-derived immature 
neurons. Stable transfection of long-term self-renewing hES cell derived neural stem cells (lt-
hESNSC) with a neuronal specific DCX-EGFP construct and subsequent selection allowed 
the generation of clonal hES cell-derived long-term self-renewing neural stem cell lines, 
which show specific and abundant expression of EGFP exclusively in immature neurons. 
Fluorescence activated cell sorting (FACS) enabled the enrichment of DCX-EGFP-positive 
immature human neurons at purities of up to over 95%. Selected neurons were amenable to 
replating and functionally mature in vitro.  
Considering that the applicability of purified hES cell-derived neurons would largely benefit 
from an efficient cryopreservation technique, defined freezing conditions were devised 
involving caspase inhibition, which enabled the storage of hES cell-derived neurons, and 
yielded post thawing survival rates up to 83%. The cryopreserved neurons were amenable to 
replating, and developed physiological properties comparable to their non-cryopreserved 
counterparts. Combined with the established lineage selection protocol, this cryopreservation 
technique enabled the generation of human neurons in a ready-to-use format for a large 
variety of biomedical applications.  
Migration studies in transwell chambers and transplantation into rodent CNS tissue revealed 
an enhanced migratory and integration potential of the DCX-EGFP purified immature 
neurons. In contrast, transplants comprising neural stem cells (NSCs) or a mixture of 
neurons and neural stem/progenitor cells showed restricted migration into the host tissue, 
accompanied by core formation. Many components are involved in the cellular and molecular 
mechanisms of neuronal migration, such as the extracellular matrix, integrins, cell adhesion 
molecules, cell junctions as well as soluble factors and their receptors. Experiments 
performed in the context of this study provided first evidence that one possible underlying 
mechanism for the effect of cluster formation and restricted emigration of donor neurons from 
neural stem/progenitor-containing grafts might be chemoattractive interactions between the 
transplanted neural stem/progenitor cells and the immature neurons. In detail, human 
neurons showed a pronounced chemoattractive migration towards undifferentiated NSCs in 
vitro. In addition, the two populations expressed complementary sets of chemoattractants 
and their respective receptors. Moreover, first results indicated that interfering with the 
suggested chemoattractive mechanisms might reduce this proposed auto-attraction between 
neural stem/progenitor cells and immature neurons. These preliminary data open the 
possibility to pharmacologically interfere with this auto-attraction mechanism. In particular, 
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the antiangiogenic drug endostatin, which interferes with the chemoattractant-mediated 
migration of endothelial cells, appears to be sufficient to induce enhanced migration out of 
mixed neural cell populations in vitro. These data should offer a starting point for the 
development of pharmacological strategies to enhance tissue integration in neural 
transplantation. 
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7. ZUSAMMENFASSUNG 
Im Rahmen dieser Dissertation wurde eine Doublecortin (DCX)-Promoter basierte 
Linienselektions-Strategie für die Generierung aufgereinigter Neurone aus humanen 
embryonaler Stammzellen (hES) entwickelt. Mittels stabiler Transfektion hES Zell-
abgeleiteter neuraler Stammzellen mit einem Konstrukt, welches das grün fluoreszierende 
Protein (EGFP) unter der Kontrolle des neuronalspezifischen DCX-Promoters exprimiert, 
wurden klonale hES Zell-abgeleitet neurale Stammzelllinien generiert, welche eine Zelltyp-
spezifische Expression von EGFP in frühen, unreifen humanen Neuronen zeigten. 
Fluoreszenz-basierte durchflusszytometrische Zellsortierung (FACS) ermöglichte die 
Aufreinigung DCX-EGFP-positiver Neurone mit Reinheitsgraden von über 95%. Die 
selektionierten Neurone konnten replatiert werden und reiften in vitro funktionell aus. 
Da die Anwendbarkeit aufgereinigter hES Zell-abgeleiteter Neurone von einer effizienten 
Kryokonservierungs-Technik profitieren würde, wurden definierte Einfrierbedingungen unter 
zu Hilfenahme von Caspaseinhibition entwickelt, welche in Überlebensraten von bis zu 83% 
resultierten. Die kryokonservierten Neurone konnten replatiert werden und entwickelten 
physiologische Eigenschaften, die mit denen nicht-kryokonservierten Kontrollzellen 
vergleichbar waren. In Kombination mit der etablierten Linienselektions-Methode ermöglichte 
diese Kryokonservierungs-Technik die Generierung von humanen Neuronen in einem 
“ready-to-use” Format, welches in einer Vielzahl von biomedizinischen Anwendungen 
genutzt werden kann.  
Transwellkammern-basierte Migrationsstudien sowie Transplantationsexperimente in das 
zentrale Nervensystem von Nagern zeigten ein gesteigertes Migration- und 
Integrationspotential der selektionierten Zellen. Im Gegensatz hierzu zeigten Reinkulturen 
neuraler Stammzellen oder Mischkulturen bestehend aus Stammzellen und Neuronen ein 
eingeschränktes Migrationtsverhalten in vitro und im Wirtsgewebe. Hier fanden sich die 
Zellen ausschließlich im Bereich des Transplantationsortes in sogenannten Zellclustern. Die 
Migration von Neuronen in vivo wird durch multiple Faktoren beeinflusset, wobei 
extrazelluläre Matrix, Integrine, Zell-Adhäsionsmoleküle, Zell-Zell-Kontakte sowie lösliche 
Faktoren und deren Rezeptoren eine Rolle spielen. 
Experimente im Rahmen dieser Studie ergaben Hinweise, dass die Clusterbildung und das 
eingeschränkte Einwandern von Spender-Neuronen in das Wirtsgehirn aus neuralen 
Stammzelltransplantaten auf eine chemoattraktive Interaktion zwischen den neuralen 
Stammzellen und den differenzierten Neuronen im Transplantat beruhen könnten. In vitro 
fand sich eine verstärkte chemoattraktive Migration von humanen Neuronen in Richtung 
neuraler Stammzellen. Zusätzlich konnte gezeigt werden, dass beide Populationen eine 
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komplementäre Expression von chemoattraktiven Faktoren und deren Rezeptoren 
aufwiesen.  
Die Interaktion mit den angenommenen chemoattraktiven Mechanismen ermöglichte eine 
Reduktion der Autoattaktion zwischen neuralen Stammzellen und unreifen Neuronen. Hier 
weisen erste Daten auf eine Mögliche pharmakologische Interaktion durch das 
antiangiogenetisches Medikament Endostatin hin, welches in die chemokinetisch-vermittelte 
Migration endothelialer Zellen eingreift. Mit dieser Substanz behandelte Zellen wiesen ein 
verstärktes Migrationsverhalten neuronaler Zellen aus neuralen Mischpopulationen in vitro 
auf. Diese Daten stellen eine Mögliche pharmakologische Strategien zur Optimierung von 
Migration und Integration neuraler Transplantate dar. 
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